{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:17:59Z","timestamp":1790637479776,"version":"4.1.0"},"reference-count":358,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11010-023-04701-7","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T15:11:13Z","timestamp":1679497873000},"page":"2813-2848","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache"],"prefix":"10.1007","volume":"478","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-8343","authenticated-orcid":false,"given":"Roger Gregory","family":"Biringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"issue":"18","key":"4701_CR1","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1001\/jama.2021.1640","volume":"325","author":"MS Robbins","year":"2021","unstructured":"Robbins MS (2021) Diagnosis and management of headache: a review. JAMA 325(18):1874\u20131885. https:\/\/doi.org\/10.1001\/jama.2021.1640","journal-title":"JAMA"},{"issue":"10283","key":"4701_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A, Krymchantowski AV, Lebedeva ER, Ravishankar K, Yu S, Sacco S, Ashina S, Younis S, Steiner TJ, Lipton RB (2021) Migraine: epidemiology and systems of care. Lancet 397(10283):1485\u20131495. https:\/\/doi.org\/10.1016\/S0140-6736(20)32160-7","journal-title":"Lancet"},{"issue":"3","key":"4701_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3949\/ccjm.58.3.257","volume":"58","author":"S Diamond","year":"1991","unstructured":"Diamond S (1991) Strategies for migraine management. Cleve Clin J Med 58(3):257\u2013261. https:\/\/doi.org\/10.3949\/ccjm.58.3.257","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"4701_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1515\/revneuro.1993.4.3.305","volume":"4","author":"JS Meyer","year":"1993","unstructured":"Meyer JS, Terayama Y, Takashima S, Obara K (1993) Cerebral circulatory changes during migraine headache with aura. Rev Neurosci 4(3):305\u2013319. https:\/\/doi.org\/10.1515\/revneuro.1993.4.3.305","journal-title":"Rev Neurosci"},{"issue":"3","key":"4701_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/WCO.0b013e32833821c1","volume":"23","author":"KC Brennan","year":"2010","unstructured":"Brennan KC, Charles A (2010) An update on the blood vessel in migraine. Curr Opin Neurol 23(3):266\u2013274. https:\/\/doi.org\/10.1097\/WCO.0b013e32833821c1","journal-title":"Curr Opin Neurol"},{"issue":"17","key":"4701_CR6","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","volume":"35","author":"R Burstein","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D (2015) Migraine: multiple processes, complex pathophysiology. J Neurosci 35(17):6619\u20136629. https:\/\/doi.org\/10.1523\/JNEUROSCI.0373-15.2015","journal-title":"J Neurosci"},{"key":"4701_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.012","volume":"338","author":"B Jacobs","year":"2016","unstructured":"Jacobs B, Dussor G (2016) Neurovascular contributions to migraine: Moving beyond vasodilation. Neuroscience 338:130\u2013144. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.06.012","journal-title":"Neuroscience"},{"issue":"4","key":"4701_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0271678X17733655","volume":"39","author":"J Hoffmann","year":"2019","unstructured":"Hoffmann J, Baca SM, Akerman S (2019) Neurovascular mechanisms of migraine and cluster headache. J Cereb Blood Flow Metab 39(4):573\u2013594. https:\/\/doi.org\/10.1177\/0271678X17733655","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"4701_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archneurpsyc.1938.02270040093005","volume":"39","author":"JR Graham","year":"1938","unstructured":"Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39(4):737\u2013763","journal-title":"Arch Neurol Psychiatry"},{"key":"4701_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1212\/wnl.14.7.636","volume":"14","author":"HT Dukes","year":"1964","unstructured":"Dukes HT, Vieth RG (1964) Cerebral arteriography during migraine prodrome and headache. Neurology 14:636\u2013639. https:\/\/doi.org\/10.1212\/wnl.14.7.636","journal-title":"Neurology"},{"issue":"5670","key":"4701_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.3.5670.569","volume":"3","author":"E Skinhoj","year":"1969","unstructured":"Skinhoj E, Paulson OB (1969) Regional blood flow in internal carotid distribution during migraine attack. Br Med J 3(5670):569\u2013570. https:\/\/doi.org\/10.1136\/bmj.3.5670.569","journal-title":"Br Med J"},{"issue":"5","key":"4701_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00333181","volume":"24","author":"T Masuzawa","year":"1983","unstructured":"Masuzawa T, Shinoda S, Furuse M, Nakahara N, Abe F, Sato F (1983) Cerebral angiographic changes on serial examination of a patient with migraine. Neuroradiology 24(5):277\u2013281. https:\/\/doi.org\/10.1007\/BF00333181","journal-title":"Neuroradiology"},{"issue":"5","key":"4701_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1526-4610.1984.hed2405245.x","volume":"24","author":"AN Lieberman","year":"1984","unstructured":"Lieberman AN, Jonas S, Hass WK, Pinto R, Lin J, Leibowitz M, Hassouri H (1984) Bilateral cervical carotid and intracranial vasospasm causing cerebral ischemia in a migrainous patient: a case of \u201cdiplegic migraine.\u201d Headache 24(5):245\u2013248. https:\/\/doi.org\/10.1111\/j.1526-4610.1984.hed2405245.x","journal-title":"Headache"},{"issue":"8148","key":"4701_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/s0140-6736(79)92692-8","volume":"2","author":"MA Moskowitz","year":"1979","unstructured":"Moskowitz MA, Reinhard JF Jr, Romero J, Melamed E, Pettibone DJ (1979) Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet 2(8148):883\u2013885. https:\/\/doi.org\/10.1016\/s0140-6736(79)92692-8","journal-title":"Lancet"},{"issue":"2","key":"4701_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","volume":"19","author":"A May","year":"1999","unstructured":"May A, Goadsby PJ (1999) The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19(2):115\u2013127. https:\/\/doi.org\/10.1097\/00004647-199902000-00001","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"4701_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00127893-200109000-00002","volume":"7","author":"SJ Tepper","year":"2001","unstructured":"Tepper SJ, Rapoport A, Sheftell F (2001) The pathophysiology of migraine. Neurologist 7(5):279\u2013286. https:\/\/doi.org\/10.1097\/00127893-200109000-00002","journal-title":"Neurologist"},{"issue":"8","key":"4701_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18(8):795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"issue":"11","key":"4701_CR18","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1177\/0333102419851810","volume":"39","author":"KA Haanes","year":"2019","unstructured":"Haanes KA, Labastida-Ram\u00edrez A, Blixt FW, Rubio-Beltr\u00e1n E, Dirven CM, Danser AH, Edvinsson L, MaassenVanDenBrink A (2019) Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models. Cephalalgia 39(11):1421\u20131434. https:\/\/doi.org\/10.1177\/0333102419851810","journal-title":"Cephalalgia"},{"issue":"8235","key":"4701_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/s0140-6736(81)92572-1","volume":"1","author":"G Burnstock","year":"1981","unstructured":"Burnstock G (1981) Pathophysiology of migraine: a new hypothesis. Lancet 1(8235):1397\u20131399. https:\/\/doi.org\/10.1016\/s0140-6736(81)92572-1","journal-title":"Lancet"},{"issue":"7","key":"4701_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrd2605","volume":"7","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7(7):575\u2013590. https:\/\/doi.org\/10.1038\/nrd2605","journal-title":"Nat Rev Drug Discov"},{"key":"4701_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-3-540-79090-7_10","volume":"194","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009) Purines and sensory nerves. Handb Exp Pharmacol 194:333\u2013392. https:\/\/doi.org\/10.1007\/978-3-540-79090-7_10","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"4701_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.113.008029","volume":"66","author":"G Burnstock","year":"2013","unstructured":"Burnstock G, Ralevic V (2013) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66(1):102\u2013192. https:\/\/doi.org\/10.1124\/pr.113.008029","journal-title":"Pharmacol Rev"},{"key":"4701_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-60327-321-3_3","volume":"574","author":"L Seminario-Vidal","year":"2009","unstructured":"Seminario-Vidal L, Lazarowski ER, Okada SF (2009) Assessment of extracellular ATP concentrations. Methods Mol Biol 574:25\u201336. https:\/\/doi.org\/10.1007\/978-1-60327-321-3_3","journal-title":"Methods Mol Biol"},{"key":"4701_CR24","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.medidd.2020.100018","volume":"4","author":"G Soslau","year":"2019","unstructured":"Soslau G (2019) Extracellular adenine compounds within the cardiovascular system: Their source, metabolism and function. Med Drug Discov 4:100018. https:\/\/doi.org\/10.1016\/j.medidd.2020.100018","journal-title":"Med Drug Discov"},{"issue":"4\u20135","key":"4701_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s002100000309","volume":"362","author":"H Zimmermann","year":"2000","unstructured":"Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362(4\u20135):299\u2013309. https:\/\/doi.org\/10.1007\/s002100000309","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4701_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1113\/jphysiol.1984.sp015385","volume":"354","author":"GV Born","year":"1984","unstructured":"Born GV, Kratzer MA (1984) Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol 354:419\u2013429. https:\/\/doi.org\/10.1113\/jphysiol.1984.sp015385","journal-title":"J Physiol"},{"issue":"10","key":"4701_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/0753-3322(89)90160-1","volume":"43","author":"E Hanington","year":"1989","unstructured":"Hanington E (1989) Migraine: the platelet hypothesis after 10 years. Biomed Pharmacother 43(10):719\u2013726. https:\/\/doi.org\/10.1016\/0753-3322(89)90160-1","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4701_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1526-4610.1986.hed2608403.x","volume":"26","author":"R Joseph","year":"1986","unstructured":"Joseph R, Welch KM, D\u2019Andrea G, Levine SR (1986) ATP hyposecretion from platelet dense bodies\u2014evidence for the purinergic hypothesis and a marker of migraine. Headache 26(8):403\u2013410. https:\/\/doi.org\/10.1111\/j.1526-4610.1986.hed2608403.x","journal-title":"Headache"},{"issue":"1","key":"4701_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/cvr\/26.1.40","volume":"26","author":"GR Bergfeld","year":"1992","unstructured":"Bergfeld GR, Forrester T (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26(1):40\u201347. https:\/\/doi.org\/10.1093\/cvr\/26.1.40","journal-title":"Cardiovasc Res"},{"issue":"27","key":"4701_CR30","doi-asserted-by":"publisher","first-page":"10986","DOI":"10.1073\/pnas.1101315108","volume":"108","author":"AM Forsyth","year":"2011","unstructured":"Forsyth AM, Wan J, Owrutsky PD, Abkarian M, Stone HA (2011) Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release. Proc Natl Acad Sci U S A 108(27):10986\u201310991. https:\/\/doi.org\/10.1073\/pnas.1101315108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4701_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/smns.1996.0023","volume":"8","author":"B Sperl\u00e1gh","year":"1996","unstructured":"Sperl\u00e1gh B, Vizi SE (1996) Neuronal synthesis, storage and release of ATP. Semin Neurosci 8(4):175\u2013186","journal-title":"Semin Neurosci"},{"issue":"5","key":"4701_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.chembiol.2017.03.010","volume":"24","author":"A Amici","year":"2017","unstructured":"Amici A, Grolla AA, Del Grosso E, Bellini R, Bianchi M, Travelli C, Garavaglia S, Sorci L, Raffaelli N, Ruggieri S, Genazzani AA, Orsomando G (2017) Synthesis and degradation of adenosine 5\u2019-tetraphosphate by nicotinamide and nicotinate phosphoribosyltransferases. Cell Chem Biol 24(5):553-564.e4. https:\/\/doi.org\/10.1016\/j.chembiol.2017.03.010","journal-title":"Cell Chem Biol"},{"issue":"10","key":"4701_CR33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCRESAHA.108.177865","volume":"103","author":"M T\u00f6lle","year":"2008","unstructured":"T\u00f6lle M, Jankowski V, Schuchardt M, Wiedon A, Huang T, Hub F, Kowalska J, Jemielity J, Guranowski A, Loddenkemper C, Zidek W, Jankowski J, van der Giet M (2008) Adenosine 5\u2019-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res 103(10):1100\u20131108. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.177865","journal-title":"Circ Res"},{"issue":"6","key":"4701_CR34","first-page":"207","volume":"6","author":"R Leira","year":"1991","unstructured":"Leira R, Castillo J, Mart\u00ednez F, Castro A, Lema M, Noya M (1991) Nucle\u00f3tidos de la adenina en la migra\u00f1a [Adenine nucleotides in migraine]. Neurologia 6(6):207\u2013210 ((in Spanish))","journal-title":"Neurologia"},{"issue":"4","key":"4701_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1468-2982.1989.0904293.x","volume":"9","author":"R Joseph","year":"1989","unstructured":"Joseph R, Welch KM, D\u2019Andrea G (1989) Serotonergic hypofunction in migraine: a synthesis of evidence based on platelet dense body dysfunction. Cephalalgia 9(4):293\u2013299. https:\/\/doi.org\/10.1046\/j.1468-2982.1989.0904293.x","journal-title":"Cephalalgia"},{"issue":"8295","key":"4701_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0140-6736(82)90459-7","volume":"2","author":"E Hanington","year":"1982","unstructured":"Hanington E, Jones RJ, Amess JA (1982) Platelet nucleotides in migraine. Lancet 2(8295):437. https:\/\/doi.org\/10.1016\/s0140-6736(82)90459-7","journal-title":"Lancet"},{"issue":"4","key":"4701_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0404.1988.tb03656.x","volume":"78","author":"C Hedman","year":"1988","unstructured":"Hedman C, Winther K, Knudsen JB (1988) Platelet function in classic migraine during attack-free periods. Acta Neurol Scand 78(4):271\u2013277. https:\/\/doi.org\/10.1111\/j.1600-0404.1988.tb03656.x","journal-title":"Acta Neurol Scand"},{"key":"4701_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1212\/wnl.11.2.116","volume":"11","author":"RW Kimball","year":"1961","unstructured":"Kimball RW, Freidman AP (1961) Further studies of neurohumoral agents in patients with vascular headaches. Neurology 11:116\u2013119. https:\/\/doi.org\/10.1212\/wnl.11.2.116","journal-title":"Neurology"},{"issue":"5","key":"4701_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/bja\/aei093","volume":"94","author":"AT Skrabanja","year":"2005","unstructured":"Skrabanja AT, Bouman EA, Dagnelie PC (2005) Potential value of adenosine 5\u2019-triphosphate (ATP) and adenosine in anaesthesia and intensive care medicine. Br J Anaesth 94(5):556\u2013562. https:\/\/doi.org\/10.1093\/bja\/aei093","journal-title":"Br J Anaesth"},{"issue":"2","key":"4701_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5633\/amm.2021.0210","volume":"60","author":"F Petrovi\u0107","year":"2021","unstructured":"Petrovi\u0107 F, Stojanov D, Aracki-Trenki\u0107 A, Petrovi\u0107 J, Petrovi\u0107 M, Jankovi\u0107 S (2021) Brain magnetic resonance spectroscopy in migraine. Acta Medica Medianae 60(2):77\u201387. https:\/\/doi.org\/10.5633\/amm.2021.0210","journal-title":"Acta Medica Medianae"},{"issue":"6","key":"4701_CR41","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1212\/wnl.42.6.1209","volume":"42","author":"B Barbiroli","year":"1992","unstructured":"Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, Pierangeli G, Zaniol P, Lugaresi E (1992) Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42(6):1209\u20131214. https:\/\/doi.org\/10.1212\/wnl.42.6.1209","journal-title":"Neurology"},{"issue":"4","key":"4701_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1212\/wnl.44.4.666","volume":"44","author":"P Montagna","year":"1994","unstructured":"Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R, Iotti S, Frassineti C, Zaniol P, Lugaresi E et al (1994) 31P-magnetic resonance spectroscopy in migraine without aura. Neurology 44(4):666\u2013669. https:\/\/doi.org\/10.1212\/wnl.44.4.666","journal-title":"Neurology"},{"issue":"6","key":"4701_CR43","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1203\/00006450-199712000-00024","volume":"42","author":"R Lodi","year":"1997","unstructured":"Lodi R, Montagna P, Soriani S, Iotti S, Arnaldi C, Cortelli P, Pierangeli G, Patuelli A, Zaniol P, Barbiroli B (1997) Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study. Pediatr Res 42(6):866\u2013871. https:\/\/doi.org\/10.1203\/00006450-199712000-00024","journal-title":"Pediatr Res"},{"issue":"2","key":"4701_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0022-510x(94)00283-t","volume":"129","author":"A Uncini","year":"1995","unstructured":"Uncini A, Lodi R, Di Muzio A, Silvestri G, Servidei S, Lugaresi A, Iotti S, Zaniol P, Barbiroli B (1995) Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci 129(2):214\u2013222. https:\/\/doi.org\/10.1016\/0022-510x(94)00283-t","journal-title":"J Neurol Sci"},{"issue":"12","key":"4701_CR45","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1177\/0333102410394675","volume":"31","author":"H Reyngoudt","year":"2011","unstructured":"Reyngoudt H, Paemeleire K, Descamps B, De Deene Y, Achten E (2011) 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients. Cephalalgia 31(12):1243\u20131253. https:\/\/doi.org\/10.1177\/0333102410394675","journal-title":"Cephalalgia"},{"issue":"Pt 12","key":"4701_CR46","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1093\/brain\/awm165","volume":"130","author":"UG Schulz","year":"2007","unstructured":"Schulz UG, Blamire AM, Corkill RG, Davies P, Styles P, Rothwell PM (2007) Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study. Brain 130(Pt 12):3102\u20133110. https:\/\/doi.org\/10.1093\/brain\/awm165","journal-title":"Brain"},{"issue":"1\u20132","key":"4701_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0009-8981(94)90146-5","volume":"227","author":"R Guieu","year":"1994","unstructured":"Guieu R, Sampi\u00e9ri F, Bechis G, Rochat H (1994) Use of HPLC to measure circulating adenosine levels in migrainous patients. Clin Chim Acta 227(1\u20132):185\u2013194. https:\/\/doi.org\/10.1016\/0009-8981(94)90146-5","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4701_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/s0317167100033497","volume":"25","author":"R Guieu","year":"1998","unstructured":"Guieu R, Devaux C, Henry H, Bechis G, Pouget J, Mallet D, Sampieri F, Juin M, Gola R, Rochat H (1998) Adenosine and migraine. Can J Neurol Sci 25(1):55\u201358. https:\/\/doi.org\/10.1017\/s0317167100033497","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"4701_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013\u20131067. https:\/\/doi.org\/10.1152\/physrev.00015.2002","journal-title":"Physiol Rev"},{"issue":"3","key":"4701_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/35058521","volume":"2","author":"BS Khakh","year":"2001","unstructured":"Khakh BS (2001) Molecular physiology of P2X receptors and ATP signalling at synapses. Nat Rev Neurosci 2(3):165\u2013174. https:\/\/doi.org\/10.1038\/35058521","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"4701_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bph.15299","volume":"178","author":"P Illes","year":"2021","unstructured":"Illes P, M\u00fcller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178(3):489\u2013514. https:\/\/doi.org\/10.1111\/bph.15299","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4701_CR52","first-page":"178","volume":"48","author":"RJ Evans","year":"1995","unstructured":"Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995) Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol 48(2):178\u2013183","journal-title":"Mol Pharmacol"},{"issue":"36","key":"4701_CR53","doi-asserted-by":"publisher","first-page":"E3455","DOI":"10.1073\/pnas.1308088110","volume":"110","author":"M Li","year":"2013","unstructured":"Li M, Silberberg SD, Swartz KJ (2013) Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+. Proc Natl Acad Sci U S A 110(36):E3455\u2013E3463. https:\/\/doi.org\/10.1073\/pnas.1308088110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6497","key":"4701_CR54","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/371516a0","volume":"371","author":"S Valera","year":"1994","unstructured":"Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G (1994) A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371(6497):516\u2013519. https:\/\/doi.org\/10.1038\/371516a0","journal-title":"Nature"},{"issue":"4","key":"4701_CR55","first-page":"283","volume":"3","author":"S Valera","year":"1995","unstructured":"Valera S, Talabot F, Evans RJ, Gos A, Antonarakis SE, Morris MA, Buell GN (1995) Characterization and chromosomal localization of a human P2X receptor from the urinary bladder. Recept Channels 3(4):283\u2013289","journal-title":"Recept Channels"},{"issue":"2","key":"4701_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1085\/jgp.20028535","volume":"120","author":"AN Eickhorst","year":"2002","unstructured":"Eickhorst AN, Berson A, Cockayne D, Lester HA, Khakh BS (2002) Control of P2X(2) channel permeability by the cytosolic domain. J Gen Physiol 120(2):119\u2013131. https:\/\/doi.org\/10.1085\/jgp.20028535","journal-title":"J Gen Physiol"},{"issue":"3","key":"4701_CR57","first-page":"1043","volume":"296","author":"M Liu","year":"2001","unstructured":"Liu M, King BF, Dunn PM, Rong W, Townsend-Nicholson A, Burnstock G (2001) Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons. J Pharmacol Exp Ther 296(3):1043\u20131050","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"4701_CR58","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1124\/mol.56.6.1171","volume":"56","author":"KJ Lynch","year":"1999","unstructured":"Lynch KJ, Touma E, Niforatos W, Kage KL, Burgard EC, van Biesen T, Kowaluk EA, Jarvis MF (1999) Molecular and functional characterization of human P2X(2) receptors. Mol Pharmacol 56(6):1171\u20131181. https:\/\/doi.org\/10.1124\/mol.56.6.1171","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4701_CR59","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1523\/JNEUROSCI.16-02-00448.1996","volume":"16","author":"P S\u00e9gu\u00e9la","year":"1996","unstructured":"S\u00e9gu\u00e9la P, Haghighi A, Soghomonian JJ, Cooper E (1996) A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain. J Neurosci 16(2):448\u2013455. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-02-00448.1996","journal-title":"J Neurosci"},{"issue":"4","key":"4701_CR60","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/mol.114.096222","volume":"87","author":"AR Ase","year":"2015","unstructured":"Ase AR, Honson NS, Zaghdane H, Pfeifer TA, S\u00e9gu\u00e9la P (2015) Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels. Mol Pharmacol 87(4):606\u2013616. https:\/\/doi.org\/10.1124\/mol.114.096222","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"4701_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0014-5793(95)01203-q","volume":"375","author":"X Bo","year":"1995","unstructured":"Bo X, Zhang Y, Nassar M, Burnstock G, Schoepfer R (1995) A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett 375(1\u20132):129\u2013133. https:\/\/doi.org\/10.1016\/0014-5793(95)01203-q","journal-title":"FEBS Lett"},{"issue":"1","key":"4701_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/j.1460-2075.1996.tb00333.x","volume":"15","author":"G Buell","year":"1996","unstructured":"Buell G, Lewis C, Collo G, North RA, Surprenant A (1996) An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J 15(1):55\u201362","journal-title":"EMBO J"},{"issue":"1","key":"4701_CR63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/mol.51.1.109","volume":"51","author":"M Garcia-Guzman","year":"1997","unstructured":"Garcia-Guzman M, Soto F, Gomez-Hernandez JM, Lund PE, St\u00fchmer W (1997) Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. Mol Pharmacol 51(1):109\u2013118. https:\/\/doi.org\/10.1124\/mol.51.1.109","journal-title":"Mol Pharmacol"},{"issue":"6","key":"4701_CR64","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1124\/mol.63.6.1407","volume":"63","author":"X Bo","year":"2003","unstructured":"Bo X, Jiang LH, Wilson HL, Kim M, Burnstock G, Surprenant A, North RA (2003) Pharmacological and biophysical properties of the human P2X5 receptor. Mol Pharmacol 63(6):1407\u20131416. https:\/\/doi.org\/10.1124\/mol.63.6.1407","journal-title":"Mol Pharmacol"},{"issue":"7","key":"4701_CR65","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","volume":"157","author":"DL Donnelly-Roberts","year":"2009","unstructured":"Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF (2009) Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 157(7):1203\u20131214. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00233.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4701_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","volume":"179","author":"AE McCarthy","year":"2019","unstructured":"McCarthy AE, Yoshioka C, Mansoor SE (2019) Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization. Cell 179(3):659-670.e13. https:\/\/doi.org\/10.1016\/j.cell.2019.09.017","journal-title":"Cell"},{"issue":"9","key":"4701_CR67","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1074\/jbc.272.9.5482","volume":"272","author":"F Rassendren","year":"1997","unstructured":"Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A (1997) The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem 272(9):5482\u20135486. https:\/\/doi.org\/10.1074\/jbc.272.9.5482","journal-title":"J Biol Chem"},{"issue":"5","key":"4701_CR68","doi-asserted-by":"publisher","first-page":"e0123089","DOI":"10.1371\/journal.pone.0123089","volume":"10","author":"RJ Soares-Bezerra","year":"2015","unstructured":"Soares-Bezerra RJ, Ferreira NC, Alberto AV, Bonavita AG, Fidalgo-Neto AA, Calheiros AS, FrutuosoVda S (2015) Alves LA (2005) An improved method for P2X7R antagonist screening. PLoS ONE 10(5):e0123089. https:\/\/doi.org\/10.1371\/journal.pone.0123089","journal-title":"PLoS ONE"},{"issue":"5262","key":"4701_CR69","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.272.5262.735","volume":"272","author":"A Surprenant","year":"1996","unstructured":"Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272(5262):735\u2013738. https:\/\/doi.org\/10.1126\/science.272.5262.735","journal-title":"Science"},{"issue":"11","key":"4701_CR70","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/emboj\/17.11.3016","volume":"17","author":"A Nicke","year":"1998","unstructured":"Nicke A, B\u00e4umert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G (1998) P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17(11):3016\u20133028. https:\/\/doi.org\/10.1093\/emboj\/17.11.3016","journal-title":"EMBO J"},{"issue":"37","key":"4701_CR71","doi-asserted-by":"publisher","first-page":"25725","DOI":"10.1074\/jbc.M803855200","volume":"283","author":"D Becker","year":"2008","unstructured":"Becker D, Woltersdorf R, Boldt W, Schmitz S, Braam U, Schmalzing G, Markwardt F (2008) The P2X7 carboxyl tail is a regulatory module of P2X7 receptor channel activity. J Biol Chem 283(37):25725\u201325734. https:\/\/doi.org\/10.1074\/jbc.M803855200","journal-title":"J Biol Chem"},{"issue":"1","key":"4701_CR72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jmb.2004.06.092","volume":"342","author":"A Aschrafi","year":"2004","unstructured":"Aschrafi A, Sadtler S, Niculescu C, Rettinger J, Schmalzing G (2004) Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes. J Mol Biol 342(1):333\u2013343. https:\/\/doi.org\/10.1016\/j.jmb.2004.06.092","journal-title":"J Mol Biol"},{"issue":"11","key":"4701_CR73","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1074\/jbc.M412265200","volume":"280","author":"NP Barrera","year":"2005","unstructured":"Barrera NP, Ormond SJ, Henderson RM, Murrell-Lagnado RD, Edwardson JM (2005) Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize. J Biol Chem 280(11):10759\u201310765. https:\/\/doi.org\/10.1074\/jbc.M412265200","journal-title":"J Biol Chem"},{"issue":"10","key":"4701_CR74","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1074\/jbc.274.10.6653","volume":"274","author":"GE Torres","year":"1999","unstructured":"Torres GE, Egan TM, Voigt MM (1999) Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 274(10):6653\u20136659. https:\/\/doi.org\/10.1074\/jbc.274.10.6653","journal-title":"J Biol Chem"},{"issue":"5","key":"4701_CR75","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1476-5381.2011.01303.x","volume":"163","author":"LS Antonio","year":"2011","unstructured":"Antonio LS, Stewart AP, Xu XJ, Varanda WA, Murrell-Lagnado RD, Edwardson JM (2011) P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. Br J Pharmacol 163(5):1069\u20131077. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01303.x","journal-title":"Br J Pharmacol"},{"issue":"8","key":"4701_CR76","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1523\/JNEUROSCI.16-08-02495.1996","volume":"16","author":"G Collo","year":"1996","unstructured":"Collo G, North RA, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A, Buell G (1996) Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16(8):2495\u20132507. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-08-02495.1996","journal-title":"J Neurosci"},{"issue":"4","key":"4701_CR77","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1124\/mol.65.4.979","volume":"65","author":"CA Jones","year":"2004","unstructured":"Jones CA, Vial C, Sellers LA, Humphrey PP, Evans RJ, Chessell IP (2004) Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel alpha beta-methylene ATP-sensitive phenotype. Mol Pharmacol 65(4):979\u2013985. https:\/\/doi.org\/10.1124\/mol.65.4.979","journal-title":"Mol Pharmacol"},{"issue":"4","key":"4701_CR78","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1471-4159.2004.02939.x","volume":"92","author":"A Nicke","year":"2005","unstructured":"Nicke A, Kerschensteiner D, Soto F (2005) Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J Neurochem 92(4):925\u2013933. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02939.x","journal-title":"J Neurochem"},{"issue":"8","key":"4701_CR79","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1161\/STROKEAHA.114.005544","volume":"45","author":"MI Harhun","year":"2014","unstructured":"Harhun MI, Povstyan OV, Albert AP, Nichols CM (2014) ATP-evoked sustained vasoconstrictions mediated by heteromeric P2X1\/4 receptors in cerebral arteries. Stroke 45(8):2444\u20132450. https:\/\/doi.org\/10.1161\/STROKEAHA.114.005544","journal-title":"Stroke"},{"issue":"21","key":"4701_CR80","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1523\/JNEUROSCI.1149-08.2008","volume":"28","author":"U Lalo","year":"2008","unstructured":"Lalo U, Pankratov Y, Wichert SP, Rossner MJ, North RA, Kirchhoff F, Verkhratsky A (2008) P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes. J Neurosci 28(21):5473\u20135480. https:\/\/doi.org\/10.1523\/JNEUROSCI.1149-08.2008","journal-title":"J Neurosci"},{"issue":"22","key":"4701_CR81","doi-asserted-by":"publisher","first-page":"15415","DOI":"10.1074\/jbc.274.22.15415","volume":"274","author":"KT L\u00ea","year":"1999","unstructured":"L\u00ea KT, Bou\u00e9-Grabot E, Archambault V, S\u00e9gu\u00e9la P (1999) Functional and biochemical evidence for heteromeric ATP-gated channels composed of P2X1 and P2X5 subunits. J Biol Chem 274(22):15415\u201315419. https:\/\/doi.org\/10.1074\/jbc.274.22.15415","journal-title":"J Biol Chem"},{"key":"4701_CR82","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fncel.2013.00250","volume":"7","author":"A Saul","year":"2013","unstructured":"Saul A, Hausmann R, Kless A, Nicke A (2013) Heteromeric assembly of P2X subunits. Front Cell Neurosci 7:250. https:\/\/doi.org\/10.3389\/fncel.2013.00250","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"4701_CR83","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1523\/JNEUROSCI.6332-11.2012","volume":"32","author":"V Compan","year":"2012","unstructured":"Compan V, Ulmann L, Stelmashenko O, Chemin J, Chaumont S, Rassendren F (2012) P2X2 and P2X5 subunits define a new heteromeric receptor with P2X7-like properties. J Neurosci 32(12):4284\u20134296. https:\/\/doi.org\/10.1523\/JNEUROSCI.6332-11.2012","journal-title":"J Neurosci"},{"issue":"17","key":"4701_CR84","doi-asserted-by":"publisher","first-page":"13930","DOI":"10.1074\/jbc.M112.345207","volume":"287","author":"R Hausmann","year":"2012","unstructured":"Hausmann R, Bodnar M, Woltersdorf R, Wang H, Fuchs M, Messemer N, Qin Y, G\u00fcnther J, Riedel T, Grohmann M, Nieber K, Schmalzing G, Rubini P, Illes P (2012) ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2\/3 and P2X2\/6 receptors. J Biol Chem 287(17):13930\u201313943. https:\/\/doi.org\/10.1074\/jbc.M112.345207","journal-title":"J Biol Chem"},{"issue":"18","key":"4701_CR85","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1523\/JNEUROSCI.18-18-07152.1998","volume":"18","author":"KT L\u00ea","year":"1998","unstructured":"L\u00ea KT, Babinski K, S\u00e9gu\u00e9la P (1998) Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 18(18):7152\u20137159. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-18-07152.1998","journal-title":"J Neurosci"},{"issue":"6220","key":"4701_CR86","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pont\u00e9n F (2015) Tissue-based map of the human proteome. Science 347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"key":"4701_CR87","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autneu.2015.04.007","volume":"191","author":"V Ralevic","year":"2015","unstructured":"Ralevic V, Dunn WR (2015) Purinergic transmission in blood vessels. Auton Neurosci 191:48\u201366. https:\/\/doi.org\/10.1016\/j.autneu.2015.04.007","journal-title":"Auton Neurosci"},{"issue":"4","key":"4701_CR88","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11302-014-9415-6","volume":"10","author":"CM Nichols","year":"2014","unstructured":"Nichols CM, Povstyan OV, Albert AP, Gordienko DV, Khan O, Vasilikostas G, Khong TK, Wan A, Reddy M, Harhun MI (2014) Vascular smooth muscle cells from small human omental arteries express P2X1 and P2X4 receptor subunits. Purinergic Signal 10(4):565\u2013572. https:\/\/doi.org\/10.1007\/s11302-014-9415-6","journal-title":"Purinergic Signal"},{"issue":"9","key":"4701_CR89","doi-asserted-by":"publisher","first-page":"e108782","DOI":"10.1371\/journal.pone.0108782","volume":"9","author":"KA Haanes","year":"2014","unstructured":"Haanes KA, Edvinsson L (2014) Expression and characterization of purinergic receptors in rat middle meningeal artery-potential role in migraine. PLoS ONE 9(9):e108782. https:\/\/doi.org\/10.1371\/journal.pone.0108782","journal-title":"PLoS ONE"},{"issue":"3 Pt 1","key":"4701_CR90","doi-asserted-by":"publisher","first-page":"C918","DOI":"10.1152\/ajpcell.1997.273.3.C918","volume":"273","author":"J Mateo","year":"1997","unstructured":"Mateo J, Miras-Portugal MT, Rotll\u00e1n P (1997) Ecto-enzymatic hydrolysis of diadenosine polyphosphates by cultured adrenomedullary vascular endothelial cells. Am J Physiol 273(3 Pt 1):C918-927. https:\/\/doi.org\/10.1152\/ajpcell.1997.273.3.C918","journal-title":"Am J Physiol"},{"issue":"6","key":"4701_CR91","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3349\/ymj.1995.36.6.487","volume":"36","author":"JW Lee","year":"1995","unstructured":"Lee JW, Kong ID, Park KS, Jeong SW (1995) Effects of adenosine tetraphosphate (ATPP) on vascular tone in the isolated rat aorta. Yonsei Med J 36(6):487\u2013496. https:\/\/doi.org\/10.3349\/ymj.1995.36.6.487","journal-title":"Yonsei Med J"},{"issue":"5","key":"4701_CR92","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.bjp.0706004","volume":"143","author":"LS Harrington","year":"2004","unstructured":"Harrington LS, Mitchell JA (2004) Novel role for P2X receptor activation in endothelium-dependent vasodilation. Br J Pharmacol 143(5):611\u2013617. https:\/\/doi.org\/10.1038\/sj.bjp.0706004","journal-title":"Br J Pharmacol"},{"issue":"5","key":"4701_CR93","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1124\/mol.107.037325","volume":"72","author":"LS Harrington","year":"2007","unstructured":"Harrington LS, Evans RJ, Wray J, Norling L, Swales KE, Vial C, Ali F, Carrier MJ, Mitchell JA (2007) Purinergic 2X1 receptors mediate endothelial dependent vasodilation to ATP. Mol Pharmacol 72(5):1132\u20131136. https:\/\/doi.org\/10.1124\/mol.107.037325","journal-title":"Mol Pharmacol"},{"issue":"5","key":"4701_CR94","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/01.res.87.5.385","volume":"87","author":"K Yamamoto","year":"2000","unstructured":"Yamamoto K, Korenaga R, Kamiya A, Ando J (2000) Fluid shear stress activates Ca(2+) influx into human endothelial cells via P2X4 purinoceptors. Circ Res 87(5):385\u2013391. https:\/\/doi.org\/10.1161\/01.res.87.5.385","journal-title":"Circ Res"},{"issue":"6","key":"4701_CR95","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/00005344-200212000-00005","volume":"40","author":"L Wang","year":"2002","unstructured":"Wang L, Karlsson L, Moses S, Hultg\u00e5rdh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40(6):841\u2013853. https:\/\/doi.org\/10.1097\/00005344-200212000-00005","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"4701_CR96","doi-asserted-by":"publisher","first-page":"H793","DOI":"10.1152\/ajpheart.01155.2002","volume":"285","author":"K Yamamoto","year":"2003","unstructured":"Yamamoto K, Sokabe T, Ohura N, Nakatsuka H, Kamiya A, Ando J (2003) Endogenously released ATP mediates shear stress-induced Ca2+ influx into pulmonary artery endothelial cells. Am J Physiol Heart Circ Physiol 285(2):H793-803. https:\/\/doi.org\/10.1152\/ajpheart.01155.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"4701_CR97","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nm1338","volume":"12","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto K, Sokabe T, Matsumoto T, Yoshimura K, Shibata M, Ohura N, Fukuda T, Sato T, Sekine K, Kato S, Isshiki M, Fujita T, Kobayashi M, Kawamura K, Masuda H, Kamiya A, Ando J (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12(1):133\u2013137. https:\/\/doi.org\/10.1038\/nm1338","journal-title":"Nat Med"},{"issue":"2","key":"4701_CR98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/10623320009072204","volume":"7","author":"A Loesch","year":"2000","unstructured":"Loesch A, Burnstock G (2000) Ultrastructural localisation of ATP-gated P2X2 receptor immunoreactivity in vascular endothelial cells in rat brain. Endothelium 7(2):93\u201398. https:\/\/doi.org\/10.3109\/10623320009072204","journal-title":"Endothelium"},{"issue":"4","key":"4701_CR99","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1046\/j.1523-1755.2003.00233.x","volume":"64","author":"GE Knight","year":"2003","unstructured":"Knight GE, Oliver-Redgate R, Burnstock G (2003) Unusual absence of endothelium-dependent or -independent vasodilatation to purines or pyrimidines in the rat renal artery. Kidney Int 64(4):1389\u20131397. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00233.x","journal-title":"Kidney Int"},{"issue":"6","key":"4701_CR100","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/sj.bjp.0701717","volume":"123","author":"SS Wildman","year":"1998","unstructured":"Wildman SS, King BF, Burnstock G (1998) Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH. Br J Pharmacol 123(6):1214\u20131220. https:\/\/doi.org\/10.1038\/sj.bjp.0701717","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4701_CR101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157016109787354123","volume":"7","author":"V Ralevic","year":"2009","unstructured":"Ralevic V (2009) Purines as neurotransmitters and neuromodulators in blood vessels. Curr Vasc Pharmacol 7(1):3\u201314. https:\/\/doi.org\/10.2174\/157016109787354123","journal-title":"Curr Vasc Pharmacol"},{"issue":"6548","key":"4701_CR102","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/377428a0","volume":"377","author":"CC Chen","year":"1995","unstructured":"Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN (1995) A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377(6548):428\u2013431. https:\/\/doi.org\/10.1038\/377428a0","journal-title":"Nature"},{"issue":"1\u20133","key":"4701_CR103","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ejphar.2013.01.018","volume":"702","author":"H Zerpa","year":"2013","unstructured":"Zerpa H, Crawford C, Knight GE, Fordham AF, Janska SE, Peppiatt-Wildman CM, Elliott J, Burnstock G, Wildman SS (2013) Extracellular ATP signaling in equine digital blood vessels. Eur J Pharmacol 702(1\u20133):242\u2013249. https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.018","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"4701_CR104","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/sj.bjp.0703760","volume":"131","author":"DP Gitterman","year":"2000","unstructured":"Gitterman DP, Evans RJ (2000) Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed. Br J Pharmacol 131(8):1561\u20131568. https:\/\/doi.org\/10.1038\/sj.bjp.0703760","journal-title":"Br J Pharmacol"},{"issue":"7","key":"4701_CR105","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/01.ATV.0000075913.00428.FD","volume":"23","author":"J Jankowski","year":"2003","unstructured":"Jankowski J, Jankowski V, Laufer U, van der Giet M, Henning L, Tepel M, Zidek W, Schl\u00fcter H (2003) Identification and quantification of diadenosine polyphosphate concentrations in human plasma. Arterioscler Thromb Vasc Biol 23(7):1231\u20131238. https:\/\/doi.org\/10.1161\/01.ATV.0000075913.00428.FD","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"4701_CR106","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/sj.bjp.0701976","volume":"124","author":"JK Phillips","year":"1998","unstructured":"Phillips JK, McLean AJ, Hill CE (1998) Receptors involved in nerve-mediated vasoconstriction in small arteries of the rat hepatic mesentery. Br J Pharmacol 124(7):1403\u20131412. https:\/\/doi.org\/10.1038\/sj.bjp.0701976","journal-title":"Br J Pharmacol"},{"issue":"Pt 3","key":"4701_CR107","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1113\/jphysiol.2003.047977","volume":"551","author":"H Kawamura","year":"2003","unstructured":"Kawamura H, Sugiyama T, Wu DM, Kobayashi M, Yamanishi S, Katsumura K, Puro DG (2003) ATP: a vasoactive signal in the pericyte-containing microvasculature of the rat retina. J Physiol 551(Pt 3):787\u2013799. https:\/\/doi.org\/10.1113\/jphysiol.2003.047977","journal-title":"J Physiol"},{"issue":"3","key":"4701_CR108","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1113\/jphysiol.2013.267294","volume":"592","author":"J Kur","year":"2014","unstructured":"Kur J, Newman EA (2014) Purinergic control of vascular tone in the retina. J Physiol 592(3):491\u2013504. https:\/\/doi.org\/10.1113\/jphysiol.2013.267294","journal-title":"J Physiol"},{"issue":"1","key":"4701_CR109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11302-020-09743-w","volume":"17","author":"K Inoue","year":"2021","unstructured":"Inoue K (2021) Nociceptive signaling of P2X receptors in chronic pain states. Purinergic Signal 17(1):41\u201347. https:\/\/doi.org\/10.1007\/s11302-020-09743-w","journal-title":"Purinergic Signal"},{"issue":"6548","key":"4701_CR110","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/377432a0","volume":"377","author":"C Lewis","year":"1995","unstructured":"Lewis C, Neidhart S, Holy C, North RA, Buell G, Surprenant A (1995) Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377(6548):432\u2013435. https:\/\/doi.org\/10.1038\/377432a0","journal-title":"Nature"},{"key":"4701_CR111","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fnmol.2017.00304","volume":"10","author":"DM Lopes","year":"2017","unstructured":"Lopes DM, Denk F, McMahon SB (2017) The molecular fingerprint of dorsal root and trigeminal ganglion neurons. Front Mol Neurosci 10:304. https:\/\/doi.org\/10.3389\/fnmol.2017.00304","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"4701_CR112","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neuroscience.2006.09.035","volume":"144","author":"V Staikopoulos","year":"2007","unstructured":"Staikopoulos V, Sessle BJ, Furness JB (2007) Jennings EA (2007) Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons. Neuroscience 144(1):208\u2013216. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.09.035","journal-title":"Neuroscience"},{"issue":"1","key":"4701_CR113","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/sj.bjp.0701803","volume":"124","author":"MG Rae","year":"1998","unstructured":"Rae MG, Rowan EG, Kennedy C (1998) Pharmacological properties of P2X3-receptors present in neurones of the rat dorsal root ganglia. Br J Pharmacol 124(1):176\u2013180. https:\/\/doi.org\/10.1038\/sj.bjp.0701803","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4701_CR114","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.bjp.0702319","volume":"126","author":"S Ueno","year":"1999","unstructured":"Ueno S, Tsuda M, Iwanaga T, Inoue K (1999) Cell type-specific ATP-activated responses in rat dorsal root ganglion neurons. Br J Pharmacol 126(2):429\u2013436. https:\/\/doi.org\/10.1038\/sj.bjp.0702319","journal-title":"Br J Pharmacol"},{"issue":"27","key":"4701_CR115","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1523\/JNEUROSCI.0628-05.2005","volume":"25","author":"RJ Rodrigues","year":"2005","unstructured":"Rodrigues RJ, Almeida T, Richardson PJ, Oliveira CR, Cunha RA (2005) Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2\/3, and P2X3 and inhibitory P2Y1, P2Y2, and\/or P2Y4 receptors in the rat hippocampus. J Neurosci 25(27):6286\u20136295. https:\/\/doi.org\/10.1523\/JNEUROSCI.0628-05.2005","journal-title":"J Neurosci"},{"issue":"2","key":"4701_CR116","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/sj.bjp.0702582","volume":"127","author":"M Tsuda","year":"1999","unstructured":"Tsuda M, Ueno S, Inoue K (1999) In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha, beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br J Pharmacol 127(2):449\u2013456. https:\/\/doi.org\/10.1038\/sj.bjp.0702582","journal-title":"Br J Pharmacol"},{"issue":"14","key":"4701_CR117","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/01.wnr.0000234740.97076.95","volume":"17","author":"EA Jennings","year":"2006","unstructured":"Jennings EA, Christie MJ, Sessle BJ (2006) ATP potentiates neurotransmission in the rat trigeminal subnucleus caudalis. NeuroReport 17(14):1507\u20131510. https:\/\/doi.org\/10.1097\/01.wnr.0000234740.97076.95","journal-title":"NeuroReport"},{"issue":"Pt 2","key":"4701_CR118","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1113\/jphysiol.2005.088435","volume":"567","author":"DA Cockayne","year":"2005","unstructured":"Cockayne DA, Dunn PM, Zhong Y, Rong W, Hamilton SG, Knight GE, Ruan HZ, Ma B, Yip P, Nunn P, McMahon SB, Burnstock G, Ford AP (2005) P2X2 knockout mice and P2X2\/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 567(Pt 2):621\u2013639. https:\/\/doi.org\/10.1113\/jphysiol.2005.088435","journal-title":"J Physiol"},{"issue":"1","key":"4701_CR119","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12974-018-1285-3","volume":"15","author":"T Long","year":"2018","unstructured":"Long T, He W, Pan Q, Zhang S, Zhang Y, Liu C, Liu Q, Qin G, Chen L, Zhou J (2018) Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation. J Neuroinflammation 15(1):245. https:\/\/doi.org\/10.1186\/s12974-018-1285-3","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4701_CR120","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s10194-019-1070-4","volume":"21","author":"T Long","year":"2020","unstructured":"Long T, He W, Pan Q, Zhang S, Zhang D, Qin G, Chen L, Zhou J (2020) Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model. J Headache Pain 21(1):4. https:\/\/doi.org\/10.1186\/s10194-019-1070-4","journal-title":"J Headache Pain"},{"issue":"2","key":"4701_CR121","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/sj.bjp.0703059","volume":"129","author":"CA Jones","year":"2000","unstructured":"Jones CA, Chessell IP, Simon J, Barnard EA, Miller KJ, Michel AD, Humphrey PP (2000) Functional characterization of the P2X(4) receptor orthologues. Br J Pharmacol 129(2):388\u2013394. https:\/\/doi.org\/10.1038\/sj.bjp.0703059","journal-title":"Br J Pharmacol"},{"issue":"12","key":"4701_CR122","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/s0028-3908(00)00070-8","volume":"39","author":"R G\u00f3mez-Villafuertes","year":"2000","unstructured":"G\u00f3mez-Villafuertes R, Gualix J, Miras-Portugal MT, Pintor J (2000) Adenosine 5\u2019-tetraphosphate (Ap(4)), a new agonist on rat midbrain synaptic terminal P2 receptors. Neuropharmacology 39(12):2381\u20132390. https:\/\/doi.org\/10.1016\/s0028-3908(00)00070-8","journal-title":"Neuropharmacology"},{"issue":"1","key":"4701_CR123","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11302-015-9481-4","volume":"12","author":"L Chen","year":"2016","unstructured":"Chen L, Liu YW, Yue K, Ru Q, Xiong Q, Ma BM, Tian X, Li CY (2016) Differential expression of ATP-gated P2X receptors in DRG between chronic neuropathic pain and visceralgia rat models. Purinergic Signal 12(1):79\u201387. https:\/\/doi.org\/10.1007\/s11302-015-9481-4","journal-title":"Purinergic Signal"},{"issue":"4","key":"4701_CR124","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neuron.2010.09.029","volume":"68","author":"WT Birdsong","year":"2010","unstructured":"Birdsong WT, Fierro L, Williams FG, Spelta V, Naves LA, Knowles M, Marsh-Haffner J, Adelman JP, Almers W, Elde RP, McCleskey EW (2010) Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels. Neuron 68(4):739\u2013749. https:\/\/doi.org\/10.1016\/j.neuron.2010.09.029","journal-title":"Neuron"},{"issue":"4","key":"4701_CR125","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/oxfordjournals.bja.a013473","volume":"84","author":"G Burnstock","year":"2000","unstructured":"Burnstock G (2000) P2X receptors in sensory neurones. Br J Anaesth 84(4):476\u2013488. https:\/\/doi.org\/10.1093\/oxfordjournals.bja.a013473","journal-title":"Br J Anaesth"},{"issue":"14","key":"4701_CR126","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1523\/JNEUROSCI.17-14-05297.1997","volume":"17","author":"R Bardoni","year":"1997","unstructured":"Bardoni R, Goldstein PA, Lee CJ, Gu JG, MacDermott AB (1997) ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J Neurosci 17(14):5297\u20135304. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-14-05297.1997","journal-title":"J Neurosci"},{"issue":"10","key":"4701_CR127","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","volume":"35","author":"B Sperl\u00e1gh","year":"2014","unstructured":"Sperl\u00e1gh B, Illes P (2014) P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci 35(10):537\u2013547. https:\/\/doi.org\/10.1016\/j.tips.2014.08.002","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"4701_CR128","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1129-2377-15-24","volume":"15","author":"F G\u00f6l\u00f6ncs\u00e9r","year":"2014","unstructured":"G\u00f6l\u00f6ncs\u00e9r F, Sperl\u00e1gh B (2014) Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine. J Headache Pain 15(1):24. https:\/\/doi.org\/10.1186\/1129-2377-15-24","journal-title":"J Headache Pain"},{"issue":"6","key":"4701_CR129","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.neuint.2010.07.009","volume":"57","author":"M D'Amico","year":"2010","unstructured":"D\u2019Amico M, Samengo I, Navarra P, Taglialatela M, Martire M (2010) AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. Neurochem Int 57(6):623\u2013628. https:\/\/doi.org\/10.1016\/j.neuint.2010.07.009","journal-title":"Neurochem Int"},{"issue":"1","key":"4701_CR130","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s10194-020-01153-y","volume":"21","author":"D Curr\u00f2","year":"2020","unstructured":"Curr\u00f2 D, Navarra P, Samengo I, Martire M (2020) P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals. J Headache Pain 21(1):83. https:\/\/doi.org\/10.1186\/s10194-020-01153-y","journal-title":"J Headache Pain"},{"key":"4701_CR131","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2147\/JIR.S313348","volume":"14","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Ye F, Du Y, Zong Y, Tang Z (2021) P2X7R in mast cells is a potential target for salicylic acid and aspirin in treatment of inflammatory pain. J Inflamm Res 14:2913\u20132931. https:\/\/doi.org\/10.2147\/JIR.S313348","journal-title":"J Inflamm Res"},{"key":"4701_CR132","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fncel.2019.00045","volume":"13","author":"D Nurkhametova","year":"2019","unstructured":"Nurkhametova D, Kudryavtsev I, Guselnikova V, Serebryakova M, Giniatullina RR, Wojciechowski S, Tore F, Rizvanov A, Koistinaho J, Malm T, Giniatullin R (2019) Activation of P2X7 receptors in peritoneal and meningeal mast cells detected by uptake of organic dyes: possible purinergic triggers of neuroinflammation in meninges. Front Cell Neurosci 13:45. https:\/\/doi.org\/10.3389\/fncel.2019.00045","journal-title":"Front Cell Neurosci"},{"issue":"6123","key":"4701_CR133","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Ko\u00e7ak E, Sen ZD, Dalkara T (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339(6123):1092\u20131095. https:\/\/doi.org\/10.1126\/science.1231897","journal-title":"Science"},{"issue":"6","key":"4701_CR134","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/brain\/awx085","volume":"140","author":"SP Chen","year":"2017","unstructured":"Chen SP, Qin T, Seidel JL, Zheng Y, Eikermann M, Ferrari MD, van den Maagdenberg AMJM, Moskowitz MA, Ayata C, Eikermann-Haerter K (2017) Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation. Brain 140(6):1643\u20131656. https:\/\/doi.org\/10.1093\/brain\/awx085","journal-title":"Brain"},{"issue":"8","key":"4701_CR135","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1523\/JNEUROSCI.22-08-03061.2002","volume":"22","author":"Y Chakfe","year":"2002","unstructured":"Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, S\u00e9gu\u00e9la P (2002) ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci 22(8):3061\u20133069. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-08-03061.2002","journal-title":"J Neurosci"},{"issue":"3","key":"4701_CR136","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3):281\u2013341. https:\/\/doi.org\/10.1124\/pr.58.3.3","journal-title":"Pharmacol Rev"},{"key":"4701_CR137","first-page":"1","volume":"33","author":"KA Jacobson","year":"2010","unstructured":"Jacobson KA (2010) P2X and P2Y receptors. Tocris Rev 33:1\u201316","journal-title":"Tocris Rev"},{"issue":"1\u20133","key":"4701_CR138","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0167-4781(01)00291-3","volume":"1521","author":"DJ Moore","year":"2001","unstructured":"Moore DJ, Chambers JK, Wahlin JP, Tan KB, Moore GB, Jenkins O, Emson PC, Murdock PR (2001) Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. Biochim Biophys Acta 1521(1\u20133):107\u2013119. https:\/\/doi.org\/10.1016\/s0167-4781(01)00291-3","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"4701_CR139","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1124\/mol.65.2.426","volume":"65","author":"GL Waldo","year":"2004","unstructured":"Waldo GL, Harden TK (2004) Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. Mol Pharmacol 65(2):426\u2013436. https:\/\/doi.org\/10.1124\/mol.65.2.426","journal-title":"Mol Pharmacol"},{"issue":"6","key":"4701_CR140","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1124\/mol.54.6.1118","volume":"54","author":"RK Palmer","year":"1998","unstructured":"Palmer RK, Boyer JL, Schachter JB, Nicholas RA, Harden TK (1998) Agonist action of adenosine triphosphates at the human P2Y1 receptor. Mol Pharmacol 54(6):1118\u20131123","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4701_CR141","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/713803703","volume":"50","author":"K Sak","year":"2000","unstructured":"Sak K, Barnard EA, J\u00e4rv J (2000) Dual effect of nucleotides on P2Y receptors. IUBMB Life 50(2):99\u2013103. https:\/\/doi.org\/10.1080\/713803703","journal-title":"IUBMB Life"},{"issue":"1","key":"4701_CR142","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0014-5793(97)00022-7","volume":"403","author":"C L\u00e9on","year":"1997","unstructured":"L\u00e9on C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403(1):26\u201330. https:\/\/doi.org\/10.1016\/s0014-5793(97)00022-7","journal-title":"FEBS Lett"},{"issue":"4","key":"4701_CR143","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1538-7836.2006.01866.x","volume":"4","author":"DM Bourdon","year":"2006","unstructured":"Bourdon DM, Mahanty SK, Jacobson KA, Boyer JL, Harden TK (2006) (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets. J Thromb Haemost 4(4):861\u2013868. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01866.x","journal-title":"J Thromb Haemost"},{"issue":"4","key":"4701_CR144","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1124\/mol.53.4.727","volume":"53","author":"B Hechler","year":"1998","unstructured":"Hechler B, Vigne P, L\u00e9on C, Breittmayer JP, Gachet C, Frelin C (1998) ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor. Mol Pharmacol 53(4):727\u2013733","journal-title":"Mol Pharmacol"},{"issue":"7","key":"4701_CR145","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/j.1476-5381.1996.tb16050.x","volume":"119","author":"TE Webb","year":"1996","unstructured":"Webb TE, Feolde E, Vigne P, Neary JT, Runberg A, Frelin C, Barnard EA (1996) The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br J Pharmacol 119(7):1385\u20131392. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb16050.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4701_CR146","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1476-5381.2009.00566.x","volume":"159","author":"G Kauffenstein","year":"2010","unstructured":"Kauffenstein G, F\u00fcrstenau CR, D\u2019Orl\u00e9ans-Juste P, S\u00e9vigny J (2010) The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation. Br J Pharmacol 159(3):576\u2013585. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00566.x","journal-title":"Br J Pharmacol"},{"issue":"5","key":"4701_CR147","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1476-5381.1996.tb15771.x","volume":"119","author":"J Pintor","year":"1996","unstructured":"Pintor J, King BF, Miras-Portugal MT, Burnstock G (1996) Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors. Br J Pharmacol 119(5):1006\u20131012. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb15771.x","journal-title":"Br J Pharmacol"},{"issue":"12","key":"4701_CR148","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1111\/jth.12035","volume":"10","author":"H Chang","year":"2012","unstructured":"Chang H, Yanachkov IB, Dix EJ, Li YF, Barnard MR, Wright GE, Michelson AD, Frelinger AL 3rd (2012) Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation. J Thromb Haemost 10(12):2573\u20132580. https:\/\/doi.org\/10.1111\/jth.12035","journal-title":"J Thromb Haemost"},{"issue":"1\u20132","key":"4701_CR149","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2003.08.021","volume":"111","author":"S Nylander","year":"2003","unstructured":"Nylander S, Mattsson C, Ramstr\u00f6m S, Lindahl TL (2003) The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation. Thromb Res 111(1\u20132):65\u201373. https:\/\/doi.org\/10.1016\/j.thromres.2003.08.021","journal-title":"Thromb Res"},{"key":"4701_CR150","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1744-8069-6-21","volume":"6","author":"SA Malin","year":"2010","unstructured":"Malin SA, Molliver DC (2010) Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Mol Pain 6:21. https:\/\/doi.org\/10.1186\/1744-8069-6-21","journal-title":"Mol Pain"},{"issue":"2","key":"4701_CR151","doi-asserted-by":"publisher","first-page":"H767","DOI":"10.1152\/ajpheart.2001.280.2.H767","volume":"280","author":"T Horiuchi","year":"2001","unstructured":"Horiuchi T, Dietrich HH, Tsugane S, Dacey RG Jr (2001) Analysis of purine- and pyrimidine-induced vascular responses in the isolated rat cerebral arteriole. Am J Physiol Heart Circ Physiol 280(2):H767-776. https:\/\/doi.org\/10.1152\/ajpheart.2001.280.2.H767","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"4701_CR152","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/01.STR.0000071527.10129.65","volume":"34","author":"T Horiuchi","year":"2003","unstructured":"Horiuchi T, Dietrich HH, Hongo K, Dacey RG Jr (2003) Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles. Stroke 34(6):1473\u20131478. https:\/\/doi.org\/10.1161\/01.STR.0000071527.10129.65","journal-title":"Stroke"},{"issue":"6","key":"4701_CR153","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/01.res.69.6.1583","volume":"69","author":"V Ralevic","year":"1991","unstructured":"Ralevic V, Burnstock G (1991) Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res 69(6):1583\u20131590. https:\/\/doi.org\/10.1161\/01.res.69.6.1583","journal-title":"Circ Res"},{"issue":"1","key":"4701_CR154","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11302-004-4742-7","volume":"1","author":"GK Olivecrona","year":"2004","unstructured":"Olivecrona GK, Gotberg M, Harnek J, Wang L, Jacobson KA, Erlinge D (2004) Coronary artery reperfusion: The ADP receptor P2Y(1) mediates early reactive hyperemia in vivo in pigs. Purinergic Signal 1(1):59\u201365. https:\/\/doi.org\/10.1007\/s11302-004-4742-7","journal-title":"Purinergic Signal"},{"issue":"47","key":"4701_CR155","doi-asserted-by":"publisher","first-page":"32209","DOI":"10.1074\/jbc.M109.032656","volume":"284","author":"CN Hess","year":"2009","unstructured":"Hess CN, Kou R, Johnson RP, Li GK, Michel T (2009) ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase. J Biol Chem 284(47):32209\u201332224. https:\/\/doi.org\/10.1074\/jbc.M109.032656","journal-title":"J Biol Chem"},{"issue":"6","key":"4701_CR156","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1152\/japplphysiol.00946.2011","volume":"111","author":"SB Bender","year":"1985","unstructured":"Bender SB, Berwick ZC, Laughlin MH (1985) Tune JD (2011) Functional contribution of P2Y1 receptors to the control of coronary blood flow. J Appl Physiol 111(6):1744\u20131750. https:\/\/doi.org\/10.1152\/japplphysiol.00946.2011","journal-title":"J Appl Physiol"},{"issue":"9","key":"4701_CR157","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00421-014-2921-y","volume":"114","author":"D Kylhammar","year":"2014","unstructured":"Kylhammar D, Bune LT, R\u00e5degran G (2014) P2Y1 and P2Y12 receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig. Eur J Appl Physiol 114(9):1995\u20132006. https:\/\/doi.org\/10.1007\/s00421-014-2921-y","journal-title":"Eur J Appl Physiol"},{"issue":"8","key":"4701_CR158","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.1007\/s12035-018-1455-4","volume":"56","author":"R Mitchell","year":"2019","unstructured":"Mitchell R, Campbell G, Mikolajczak M, McGill K, Mahad D, Fleetwood-Walker SM (2019) A targeted mutation disrupting mitochondrial complex IV function in primary afferent neurons leads to pain hypersensitivity through P2Y1 receptor activation. Mol Neurobiol 56(8):5917\u20135933. https:\/\/doi.org\/10.1007\/s12035-018-1455-4","journal-title":"Mol Neurobiol"},{"key":"4701_CR159","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2016.01.042","volume":"1636","author":"P Barrag\u00e1n-Iglesias","year":"2016","unstructured":"Barrag\u00e1n-Iglesias P, Pineda-Farias JB, Bravo-Hern\u00e1ndez M, Cervantes-Dur\u00e1n C, Price TJ, Murbarti\u00e1n J, Granados-Soto V (2016) Predominant role of spinal P2Y1 receptors in the development of neuropathic pain in rats. Brain Res 1636:43\u201351. https:\/\/doi.org\/10.1016\/j.brainres.2016.01.042","journal-title":"Brain Res"},{"key":"4701_CR160","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.brainresbull.2017.01.019","volume":"130","author":"SG Kwon","year":"2017","unstructured":"Kwon SG, Roh DH, Yoon SY, Choi SR, Choi HS, Moon JY, Kang SY, Beitz AJ, Lee JH (2017) Involvement of peripheral P2Y1 receptors and potential interaction with IL-1 receptors in IL-1\u03b2-induced thermal hypersensitivity in rats. Brain Res Bull 130:165\u2013172. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.01.019","journal-title":"Brain Res Bull"},{"issue":"2","key":"4701_CR161","doi-asserted-by":"publisher","first-page":"L376","DOI":"10.1152\/ajplung.00447.2002","volume":"285","author":"R Schafer","year":"2003","unstructured":"Schafer R, Sedehizade F, Welte T, Reiser G (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol 285(2):L376-385. https:\/\/doi.org\/10.1152\/ajplung.00447.2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"19","key":"4701_CR162","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1021\/jm020046y","volume":"45","author":"KA Jacobson","year":"2002","unstructured":"Jacobson KA, Jarvis MF, Williams M (2002) Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45(19):4057\u20134093. https:\/\/doi.org\/10.1021\/jm020046y","journal-title":"J Med Chem"},{"issue":"1","key":"4701_CR163","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1021\/jm010369e","volume":"45","author":"HS Kim","year":"2002","unstructured":"Kim HS, Ravi RG, Marquez VE, Maddileti S, Wihlborg AK, Erlinge D, Malmsj\u00f6 M, Boyer JL, Harden TK, Jacobson KA (2002) Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors. J Med Chem 45(1):208\u2013218. https:\/\/doi.org\/10.1021\/jm010369e","journal-title":"J Med Chem"},{"issue":"1","key":"4701_CR164","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/j.1476-5381.1995.tb16382.x","volume":"116","author":"ER Lazarowski","year":"1995","unstructured":"Lazarowski ER, Watt WC, Stutts MJ, Boucher RC, Harden TK (1995) Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol 116(1):1619\u20131627. https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16382.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4701_CR165","first-page":"413","volume":"50","author":"V Ralevic","year":"1998","unstructured":"Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413\u2013492","journal-title":"Pharmacol Rev"},{"issue":"4","key":"4701_CR166","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0165-6147(00)89001-x","volume":"16","author":"MR Boarder","year":"1995","unstructured":"Boarder MR, Weisman GA, Turner JT, Wilkinson GF (1995) G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol Sci 16(4):133\u2013139. https:\/\/doi.org\/10.1016\/s0165-6147(00)89001-x","journal-title":"Trends Pharmacol Sci"},{"issue":"21","key":"4701_CR167","doi-asserted-by":"publisher","first-page":"11009","DOI":"10.3390\/ijerph182111009","volume":"18","author":"M Shihan","year":"2021","unstructured":"Shihan M, Novoyatleva T, Lehmeyer T, Sydykov A, Schermuly RT (2021) Role of the purinergic P2Y2 receptor in pulmonary hypertension. Int J Environ Res Public Health 18(21):11009. https:\/\/doi.org\/10.3390\/ijerph182111009","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4701_CR168","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1124\/mol.104.006908","volume":"67","author":"C Alvarado-Castillo","year":"2005","unstructured":"Alvarado-Castillo C, Harden TK, Boyer JL (2005) Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2. Mol Pharmacol 67(1):114\u2013122. https:\/\/doi.org\/10.1124\/mol.104.006908","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4701_CR169","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/sj.bjp.0706326","volume":"146","author":"PJ Guns","year":"2005","unstructured":"Guns PJ, Korda A, Crauwels HM, Van Assche T, Robaye B, Boeynaems JM, Bult H (2005) Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol 146(2):288\u2013295. https:\/\/doi.org\/10.1038\/sj.bjp.0706326","journal-title":"Br J Pharmacol"},{"issue":"8","key":"4701_CR170","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1172\/JCI81067","volume":"125","author":"S Wang","year":"2015","unstructured":"Wang S, Iring A, Strilic B, Albarr\u00e1n Ju\u00e1rez J, Kaur H, Troidl K, Tonack S, Burbiel JC, M\u00fcller CE, Fleming I, Lundberg JO, Wettschureck N, Offermanns S (2015) P2Y2 and Gq\/G11 control blood pressure by mediating endothelial mechanotransduction. J Clin Invest 125(8):3077\u20133086. https:\/\/doi.org\/10.1172\/JCI81067","journal-title":"J Clin Invest"},{"issue":"10","key":"4701_CR171","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1046\/j.1460-9568.2002.02253.x","volume":"16","author":"DC Molliver","year":"2002","unstructured":"Molliver DC, Cook SP, Carlsten JA, Wright DE, McCleskey EW (2002) ATP and UTP excite sensory neurons and induce CREB phosphorylation through the metabotropic receptor, P2Y2. Eur J Neurosci 16(10):1850\u20131860. https:\/\/doi.org\/10.1046\/j.1460-9568.2002.02253.x","journal-title":"Eur J Neurosci"},{"issue":"1","key":"4701_CR172","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbrc.2007.07.148","volume":"362","author":"E Niederberger","year":"2007","unstructured":"Niederberger E, Ehnert C, Gao W, Coste O, Schmidtko A, Popp L, Gall CV, Korf HW, Tegeder I, Geisslinger G (2007) The impact of CREB and its phosphorylation at Ser142 on inflammatory nociception. Biochem Biophys Res Commun 362(1):75\u201380. https:\/\/doi.org\/10.1016\/j.bbrc.2007.07.148","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4701_CR173","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.pain.2008.01.026","volume":"138","author":"SA Malin","year":"2008","unstructured":"Malin SA, Davis BM, Koerber RH, Reynolds IJ, Albers KM, Molliver DC (2008) Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2. Pain 138(3):484\u2013496. https:\/\/doi.org\/10.1016\/j.pain.2008.01.026","journal-title":"Pain"},{"issue":"7","key":"4701_CR174","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/glia.22819","volume":"63","author":"G Magni","year":"2015","unstructured":"Magni G, Merli D, Verderio C, Abbracchio MP, Ceruti S (2015) P2Y2 receptor antagonists as anti-allodynic agents in acute and sub-chronic trigeminal sensitization: role of satellite glial cells. Glia 63(7):1256\u20131269. https:\/\/doi.org\/10.1002\/glia.22819","journal-title":"Glia"},{"issue":"6","key":"4701_CR175","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/sj.bjp.0702909","volume":"128","author":"D Communi","year":"1999","unstructured":"Communi D, Robaye B, Boeynaems JM (1999) Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128(6):1199\u20131206. https:\/\/doi.org\/10.1038\/sj.bjp.0702909","journal-title":"Br J Pharmacol"},{"key":"4701_CR176","unstructured":"Invitrogen (2008). GeneBLAzer\u00ae validation Packet (Version No.: 01Sep08). https:\/\/tools.thermofisher.com\/content\/sfs\/manuals\/P2RY11-DA-and-D.pdf"},{"issue":"6","key":"4701_CR177","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1124\/mol.63.6.1356","volume":"63","author":"PJ White","year":"2003","unstructured":"White PJ, Webb TE, Boarder MR (2003) Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling. Mol Pharmacol 63(6):1356\u20131363. https:\/\/doi.org\/10.1124\/mol.63.6.1356","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"4701_CR178","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/a:1007168215748","volume":"213","author":"L van der Weyden","year":"2000","unstructured":"van der Weyden L, Adams DJ, Luttrell BM, Conigrave AD, Morris MB (2000) Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines. Mol Cell Biochem 213(1\u20132):75\u201381. https:\/\/doi.org\/10.1023\/a:1007168215748","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"4701_CR179","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1124\/mol.60.6.1375","volume":"60","author":"AD Qi","year":"2001","unstructured":"Qi AD, Zambon AC, Insel PA, Nicholas RA (2001) An arginine\/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors. Mol Pharmacol 60(6):1375\u20131382. https:\/\/doi.org\/10.1124\/mol.60.6.1375","journal-title":"Mol Pharmacol"},{"issue":"4","key":"4701_CR180","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1046\/j.1440-1711.2000.00918.x","volume":"78","author":"L van der Weyden","year":"2000","unstructured":"van der Weyden L, Conigrave AD, Morris MB (2000) Signal transduction and white cell maturation via extracellular ATP and the P2Y11 receptor. Immunol Cell Biol 78(4):369\u2013374. https:\/\/doi.org\/10.1046\/j.1440-1711.2000.00918.x","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"4701_CR181","doi-asserted-by":"publisher","first-page":"H1688","DOI":"10.1152\/ajpheart.00576.2003","volume":"286","author":"C Liu","year":"2004","unstructured":"Liu C, Mather S, Huang Y, Garland CJ, Yao X (2004) Extracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries. Am J Physiol Heart Circ Physiol 286(5):H1688-1695. https:\/\/doi.org\/10.1152\/ajpheart.00576.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"4701_CR182","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11010-017-2973-5","volume":"431","author":"MD D\u0103nil\u0103","year":"2017","unstructured":"D\u0103nil\u0103 MD, Privistirescu A, Duicu OM, Ra\u021biu CD, Angoulvant D, Muntean DM, Sturza A (2017) The effect of purinergic signaling via the P2Y11 receptor on vascular function in a rat model of acute inflammation. Mol Cell Biochem 431(1\u20132):37\u201344. https:\/\/doi.org\/10.1007\/s11010-017-2973-5","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"4701_CR183","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/ijms22020855","volume":"22","author":"M Piollet","year":"2021","unstructured":"Piollet M, Sturza A, Chadet S, Gabillard-Lefort C, Benoist L, Muntean DM, Aburel OM, Angoulvant D, Ivanes F (2021) P2Y11 agonism prevents hypoxia\/reoxygenation- and angiotensin ii-induced vascular dysfunction and intimal hyperplasia development. Int J Mol Sci 22(2):855. https:\/\/doi.org\/10.3390\/ijms22020855","journal-title":"Int J Mol Sci"},{"key":"4701_CR184","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1744-8069-10-29","volume":"10","author":"P Barrag\u00e1n-Iglesias","year":"2014","unstructured":"Barrag\u00e1n-Iglesias P, Pineda-Farias JB, Cervantes-Dur\u00e1n C, Bravo-Hern\u00e1ndez M, Rocha-Gonz\u00e1lez HI, Murbarti\u00e1n J, Granados-Soto V (2014) Role of spinal P2Y6 and P2Y11 receptors in neuropathic pain in rats: possible involvement of glial cells. Mol Pain 10:29. https:\/\/doi.org\/10.1186\/1744-8069-10-29","journal-title":"Mol Pain"},{"key":"4701_CR185","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pbb.2014.11.001","volume":"128","author":"P Barrag\u00e1n-Iglesias","year":"2015","unstructured":"Barrag\u00e1n-Iglesias P, Mendoza-Garc\u00e9s L, Pineda-Farias JB, Solano-Olivares V, Rodr\u00edguez-Silverio J, Flores-Murrieta FJ, Granados-Soto V, Rocha-Gonz\u00e1lez HI (2015) Participation of peripheral P2Y1, P2Y6 and P2Y11 receptors in formalin-induced inflammatory pain in rats. Pharmacol Biochem Behav 128:23\u201332. https:\/\/doi.org\/10.1016\/j.pbb.2014.11.001","journal-title":"Pharmacol Biochem Behav"},{"issue":"35","key":"4701_CR186","doi-asserted-by":"publisher","first-page":"31390","DOI":"10.1074\/jbc.M110714200","volume":"277","author":"J Simon","year":"2002","unstructured":"Simon J, Filippov AK, G\u00f6ransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277(35):31390\u201331400. https:\/\/doi.org\/10.1074\/jbc.M110714200","journal-title":"J Biol Chem"},{"issue":"10","key":"4701_CR187","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2002-10-3027","volume":"101","author":"Z Ding","year":"2003","unstructured":"Ding Z, Kim S, Dorsam RT, Jin J, Kunapuli SP (2003) Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood 101(10):3908\u20133914. https:\/\/doi.org\/10.1182\/blood-2002-10-3027","journal-title":"Blood"},{"issue":"5","key":"4701_CR188","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1124\/mol.64.5.1210","volume":"64","author":"ET Bodor","year":"2003","unstructured":"Bodor ET, Waldo GL, Hooks SB, Corbitt J, Boyer JL, Harden TK (2003) Purification and functional reconstitution of the human P2Y12 receptor. Mol Pharmacol 64(5):1210\u20131216. https:\/\/doi.org\/10.1124\/mol.64.5.1210","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4701_CR189","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1124\/jpet.301.2.705","volume":"301","author":"FL Zhang","year":"2002","unstructured":"Zhang FL, Luo L, Gustafson E, Palmer K, Qiao X, Fan X, Yang S, Laz TM, Bayne M, Monsma F Jr (2002) P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301(2):705\u2013713. https:\/\/doi.org\/10.1124\/jpet.301.2.705","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 2","key":"4701_CR190","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1042\/BJ20020226","volume":"368","author":"TM Quinton","year":"2002","unstructured":"Quinton TM, Kim S, Dangelmaier C, Dorsam RT, Jin J, Daniel JL, Kunapuli SP (2002) Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Biochem J 368(Pt 2):535\u2013543. https:\/\/doi.org\/10.1042\/BJ20020226","journal-title":"Biochem J"},{"issue":"49","key":"4701_CR191","doi-asserted-by":"publisher","first-page":"47588","DOI":"10.1074\/jbc.M208778200","volume":"277","author":"RT Dorsam","year":"2002","unstructured":"Dorsam RT, Kim S, Jin J, Kunapuli SP (2002) Coordinated signaling through both G12\/13 and G(i) pathways is sufficient to activate GPIIb\/IIIa in human platelets. J Biol Chem 277(49):47588\u201347595. https:\/\/doi.org\/10.1074\/jbc.M208778200","journal-title":"J Biol Chem"},{"issue":"13","key":"4701_CR192","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/sj.onc.1204190","volume":"20","author":"MK Ho","year":"2001","unstructured":"Ho MK, Wong YH (2001) G(z) signaling: emerging divergence from G(i) signaling. Oncogene 20(13):1615\u20131625. https:\/\/doi.org\/10.1038\/sj.onc.1204190","journal-title":"Oncogene"},{"issue":"10","key":"4701_CR193","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/01.ATV.0000142376.30582.ed","volume":"24","author":"AK Wihlborg","year":"2004","unstructured":"Wihlborg AK, Wang L, Braun OO, Eyjolfsson A, Gustafsson R, Gudbjartsson T, Erlinge D (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24(10):1810\u20131815. https:\/\/doi.org\/10.1161\/01.ATV.0000142376.30582.ed","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"4701_CR194","doi-asserted-by":"publisher","first-page":"e00338","DOI":"10.1002\/prp2.338","volume":"5","author":"M Rey","year":"2017","unstructured":"Rey M, Kramberg M, Hess P, Morrison K, Ernst R, Haag F, Weber E, Clozel M, Baumann M, Caroff E, Hubler F, Riederer MA, Steiner B (2017) The reversible P2Y12 antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat. Pharmacol Res Perspect 5(5):e00338. https:\/\/doi.org\/10.1002\/prp2.338","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"4701_CR195","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1526-4610.1990.hed3005269.x","volume":"30","author":"T Skyh\u00f8j Olsen","year":"1990","unstructured":"Skyh\u00f8j Olsen T (1990) Migraine with and without aura: the same disease due to cerebral vasospasm of different intensity. A hypothesis based on CBF studies during migraine. Headache 30(5):269\u2013272. https:\/\/doi.org\/10.1111\/j.1526-4610.1990.hed3005269.x","journal-title":"Headache"},{"issue":"23","key":"4701_CR196","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1111\/bph.15641","volume":"178","author":"F G\u00f6l\u00f6ncs\u00e9r","year":"2021","unstructured":"G\u00f6l\u00f6ncs\u00e9r F, Baranyi M, Iring A, Hricis\u00e1k L, Otrokocsi L, Beny\u00f3 Z, Sperl\u00e1gh B (2021) Involvement of P2Y12 receptors in a nitroglycerin-induced model of migraine in male mice. Br J Pharmacol 178(23):4626\u20134645. https:\/\/doi.org\/10.1111\/bph.15641","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4701_CR197","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-019-1603-4","volume":"16","author":"F Jing","year":"2019","unstructured":"Jing F, Zhang Y, Long T, He W, Qin G, Zhang D, Chen L, Zhou J (2019) P2Y12 receptor mediates microglial activation via RhoA\/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine. J Neuroinflammation 16(1):217. https:\/\/doi.org\/10.1186\/s12974-019-1603-4","journal-title":"J Neuroinflammation"},{"issue":"3","key":"4701_CR198","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41419-019-1425-4","volume":"10","author":"T Yu","year":"2019","unstructured":"Yu T, Zhang X, Shi H, Tian J, Sun L, Hu X, Cui W, Du D (2019) P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents. Cell Death Dis 10(3):165. https:\/\/doi.org\/10.1038\/s41419-019-1425-4","journal-title":"Cell Death Dis"},{"issue":"11","key":"4701_CR199","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1523\/JNEUROSCI.5589-07.2008","volume":"28","author":"K Kobayashi","year":"2008","unstructured":"Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K (2008) P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 28(11):2892\u20132902. https:\/\/doi.org\/10.1523\/JNEUROSCI.5589-07.2008","journal-title":"J Neurosci"},{"issue":"6","key":"4701_CR200","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/life10060092","volume":"10","author":"R Tsuchida","year":"2020","unstructured":"Tsuchida R, Sumitani M, Abe H, Ando M, Saita K, Hattori K, Mietani K, Inoue R, Uchida K (2020) Clopidogrel, an ADP-P2Y12 receptor antagonist, can prevent severe postoperative pain: a retrospective chart review. Life (Basel) 10(6):92. https:\/\/doi.org\/10.3390\/life10060092","journal-title":"Life (Basel)"},{"key":"4701_CR201","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2147\/JPR.S137131","volume":"10","author":"PW Liu","year":"2017","unstructured":"Liu PW, Yue MX, Zhou R, Niu J, Huang DJ, Xu T, Luo P, Liu XH, Zeng JW (2017) P2Y12 and P2Y13 receptors involved in ADP\u03b2s induced the release of IL-1\u03b2, IL-6 and TNF-\u03b1 from cultured dorsal horn microglia. J Pain Res 10:1755\u20131767. https:\/\/doi.org\/10.2147\/JPR.S137131","journal-title":"J Pain Res"},{"issue":"7","key":"4701_CR202","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1526-4610.2005.05135.x","volume":"45","author":"F Perini","year":"2005","unstructured":"Perini F, D\u2019Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926\u2013931. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05135.x","journal-title":"Headache"},{"issue":"5","key":"4701_CR203","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1533-2500.2009.00301.x","volume":"9","author":"A Ko\u00e7er","year":"2009","unstructured":"Ko\u00e7er A, Memi\u015fo\u011fullari R, Doma\u00e7 FM, Ilhan A, Ko\u00e7er E, Okuyucu S, Ozdemir B, Y\u00fcksel H (2009) IL-6 levels in migraine patients receiving topiramate. Pain Pract 9(5):375\u2013379. https:\/\/doi.org\/10.1111\/j.1533-2500.2009.00301.x","journal-title":"Pain Pract"},{"issue":"1","key":"4701_CR204","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1124\/mol.64.1.104","volume":"64","author":"F Marteau","year":"2003","unstructured":"Marteau F, Le Poul E, Communi D, Communi D, Labouret C, Savi P, Boeynaems JM, Gonzalez NS (2003) Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 64(1):104\u2013112. https:\/\/doi.org\/10.1124\/mol.64.1.104","journal-title":"Mol Pharmacol"},{"issue":"44","key":"4701_CR205","doi-asserted-by":"publisher","first-page":"41479","DOI":"10.1074\/jbc.M105912200","volume":"276","author":"D Communi","year":"2001","unstructured":"Communi D, Gonzalez NS, Detheux M, Br\u00e9zillon S, Lannoy V, Parmentier M, Boeynaems JM (2001) Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276(44):41479\u201341485. https:\/\/doi.org\/10.1074\/jbc.M105912200","journal-title":"J Biol Chem"},{"issue":"2","key":"4701_CR206","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2005.04.021","volume":"70","author":"YC Kim","year":"2005","unstructured":"Kim YC, Lee JS, Sak K, Marteau F, Mamedova L, Boeynaems JM, Jacobson KA (2005) Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochem Pharmacol 70(2):266\u2013274. https:\/\/doi.org\/10.1016\/j.bcp.2005.04.021","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"4701_CR207","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.3390\/ijms22073468","volume":"22","author":"C Dsouza","year":"2021","unstructured":"Dsouza C, Komarova SV (2021) Characterization of potency of the P2Y13 receptor agonists: a meta-analysis. Int J Mol Sci 22(7):3468. https:\/\/doi.org\/10.3390\/ijms22073468","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4701_CR208","doi-asserted-by":"publisher","first-page":"e91890","DOI":"10.1371\/journal.pone.0091890","volume":"9","author":"FR Giachini","year":"2014","unstructured":"Giachini FR, Leite R, Osmond DA, Lima VV, Inscho EW, Webb RC, Tostes RC (2014) Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats. PLoS ONE 9(3):e91890. https:\/\/doi.org\/10.1371\/journal.pone.0091890","journal-title":"PLoS ONE"},{"key":"4701_CR209","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2147\/JPR.S154437","volume":"11","author":"R Zhou","year":"2018","unstructured":"Zhou R, Xu T, Liu X, Chen Y, Kong D, Tian H, Yue M, Huang D, Zeng J (2018) Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1\u03b2 and IL-6 in rats with diabetic neuropathic pain. J Pain Res 11:615\u2013628. https:\/\/doi.org\/10.2147\/JPR.S154437","journal-title":"J Pain Res"},{"issue":"2","key":"4701_CR210","doi-asserted-by":"publisher","first-page":"G492","DOI":"10.1152\/ajpgi.00257.2006","volume":"292","author":"N Gao","year":"2007","unstructured":"Gao N, Hu HZ, Liu S, Gao C, Xia Y, Wood JD (2007) Stimulation of adenosine A1 and A2A receptors by AMP in the submucosal plexus of guinea pig small intestine. Am J Physiol Gastrointest Liver Physiol 292(2):G492-500. https:\/\/doi.org\/10.1152\/ajpgi.00257.2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"4701_CR211","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1124\/jpet.106.112250","volume":"320","author":"SJ Mustafa","year":"2007","unstructured":"Mustafa SJ, Nadeem A, Fan M, Zhong H, Belardinelli L, Zeng D (2007) Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 320(3):1246\u20131251. https:\/\/doi.org\/10.1124\/jpet.106.112250","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"4701_CR212","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bmcl.2017.11.019","volume":"28","author":"JK Holien","year":"2018","unstructured":"Holien JK, Seibt B, Roberts V, Salvaris E, Parker MW, Cowan PJ, Dwyer KM (2018) AMP and adenosine are both ligands for adenosine 2B receptor signaling. Bioorg Med Chem Lett 28(2):202\u2013206. https:\/\/doi.org\/10.1016\/j.bmcl.2017.11.019","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"4701_CR213","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1074\/jbc.M111.291666","volume":"287","author":"JE Rittiner","year":"2012","unstructured":"Rittiner JE, Korboukh I, Hull-Ryde EA, Jin J, Janzen WP, Frye SV, Zylka MJ (2012) AMP is an adenosine A1 receptor agonist. J Biol Chem 287(8):5301\u20135309. https:\/\/doi.org\/10.1074\/jbc.M111.291666","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"4701_CR214","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0014-5793(96)00732-6","volume":"391","author":"J Gualix","year":"1996","unstructured":"Gualix J, Abal M, Pintor J, Miras-Portugal MT (1996) Presence of epsilon-adenosine tetraphosphate in chromaffin granules after transport of epsilon-ATP. FEBS Lett 391(1\u20132):195\u2013198. https:\/\/doi.org\/10.1016\/0014-5793(96)00732-6","journal-title":"FEBS Lett"},{"issue":"5","key":"4701_CR215","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000136714","volume":"15","author":"K Van Dyke","year":"1977","unstructured":"Van Dyke K, Robinson R, Urquilla P, Smith D, Taylor M, Trush M, Wilson M (1977) An analysis of nucleotides and catecholamines in bovine medullary granules by anion exchange high pressure liquid chromatography and fluorescence. Evidence that most of the catecholamines in chromaffin granules are stored without associated ATP. Pharmacology 15(5):377\u2013391. https:\/\/doi.org\/10.1159\/000136714","journal-title":"Pharmacology"},{"issue":"20","key":"4701_CR216","doi-asserted-by":"publisher","first-page":"17735","DOI":"10.1074\/jbc.M300288200","volume":"278","author":"T Westhoff","year":"2003","unstructured":"Westhoff T, Jankowski J, Schmidt S, Luo J, Giebing G, Schl\u00fcter H, Tepel M, Zidek W, van der Giet M (2003) Identification and characterization of adenosine 5\u2019-tetraphosphate in human myocardial tissue. J Biol Chem 278(20):17735\u201317740. https:\/\/doi.org\/10.1074\/jbc.M300288200","journal-title":"J Biol Chem"},{"issue":"4","key":"4701_CR217","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/pl00005279","volume":"358","author":"SM Hourani","year":"1998","unstructured":"Hourani SM, Bailey SJ, Johnson CR, Tennant JP (1998) Effects of adenosine 5\u2019-triphosphate, uridine 5\u2019-triphosphate, adenosine 5\u2019-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae. Naunyn Schmiedebergs Arch Pharmacol 358(4):464\u2013473. https:\/\/doi.org\/10.1007\/pl00005279","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1\u20132","key":"4701_CR218","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/s0014-5793(98)00560-2","volume":"430","author":"MT Miras-Portugal","year":"1998","unstructured":"Miras-Portugal MT, Gualix J, Pintor J (1998) The neurotransmitter role of diadenosine polyphosphates. FEBS Lett 430(1\u20132):78\u201382. https:\/\/doi.org\/10.1016\/s0014-5793(98)00560-2","journal-title":"FEBS Lett"},{"issue":"1","key":"4701_CR219","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0006-291x(83)90997-x","volume":"115","author":"J L\u00fcthje","year":"1983","unstructured":"L\u00fcthje J, Ogilvie A (1983) The presence of diadenosine 5\u2019,5\u2019\u2019\u2019-P1, P3-triphosphate (Ap3A) in human platelets. Biochem Biophys Res Commun 115(1):253\u2013260. https:\/\/doi.org\/10.1016\/0006-291x(83)90997-x","journal-title":"Biochem Biophys Res Commun"},{"issue":"6459","key":"4701_CR220","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/367186a0","volume":"367","author":"H Schl\u00fcter","year":"1994","unstructured":"Schl\u00fcter H, Offers E, Br\u00fcggemann G, van der Giet M, Tepel M, Nordhoff E, Karas M, Spieker C, Witzel H, Zidek W (1994) Diadenosine phosphates and the physiological control of blood pressure. Nature 367(6459):186\u2013188. https:\/\/doi.org\/10.1038\/367186a0","journal-title":"Nature"},{"issue":"6","key":"4701_CR221","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1474-8673.1996.tb00053.x","volume":"16","author":"H Schl\u00fcter","year":"1996","unstructured":"Schl\u00fcter H, Tepel M, Zidek W (1996) Vascular actions of diadenosine phosphates. J Auton Pharmacol 16(6):357\u2013362. https:\/\/doi.org\/10.1111\/j.1474-8673.1996.tb00053.x","journal-title":"J Auton Pharmacol"},{"issue":"6 Pt 1","key":"4701_CR222","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1161\/01.hyp.26.6.899","volume":"26","author":"E Schulze-Lohoff","year":"1995","unstructured":"Schulze-Lohoff E, Zanner S, Ogilvie A, Sterzel RB (1995) Vasoactive diadenosine polyphosphates promote growth of cultured renal mesangial cells. Hypertension 26(6 Pt 1):899\u2013904. https:\/\/doi.org\/10.1161\/01.hyp.26.6.899","journal-title":"Hypertension"},{"issue":"34","key":"4701_CR223","doi-asserted-by":"publisher","first-page":"23926","DOI":"10.1074\/jbc.274.34.23926","volume":"274","author":"J Jankowski","year":"1999","unstructured":"Jankowski J, Tepel M, van der Giet M, Tente IM, Henning L, Junker R, Zidek W, Schl\u00fcter H (1999) Identification and characterization of P(1), P(7)-Di(adenosine-5\u2019)-heptaphosphate from human platelets. J Biol Chem 274(34):23926\u201323931. https:\/\/doi.org\/10.1074\/jbc.274.34.23926","journal-title":"J Biol Chem"},{"issue":"6","key":"4701_CR224","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/j.1471-4159.1988.tb01147.x","volume":"51","author":"A Rodriguez del Castillo","year":"1988","unstructured":"Rodriguez del Castillo A, Torres M, Delicado EG, Miras-Portugal MT (1988) Subcellular distribution studies of diadenosine polyphosphates\u2014Ap4A and Ap5A\u2014in bovine adrenal medulla: presence in chromaffin granules. J Neurochem 51(6):1696\u20131703. https:\/\/doi.org\/10.1111\/j.1471-4159.1988.tb01147.x","journal-title":"J Neurochem"},{"issue":"2","key":"4701_CR225","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0003-2697(92)90469-n","volume":"200","author":"J Pintor","year":"1992","unstructured":"Pintor J, Rotll\u00e1n P, Torres M, Miras-Portugal MT (1992) Characterization and quantification of diadenosine hexaphosphate in chromaffin cells: granular storage and secretagogue-induced release. Anal Biochem 200(2):296\u2013300. https:\/\/doi.org\/10.1016\/0003-2697(92)90469-n","journal-title":"Anal Biochem"},{"issue":"Pt 2","key":"4701_CR226","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1469-7793.1997.327be.x","volume":"504","author":"J Pintor","year":"1997","unstructured":"Pintor J, Puche JA, Gualix J, Hoyle CH, Miras-Portugal MT (1997) Diadenosine polyphosphates evoke Ca2+ transients in guinea-pig brain via receptors distinct from those for ATP. J Physiol 504(Pt 2):327\u2013335. https:\/\/doi.org\/10.1111\/j.1469-7793.1997.327be.x","journal-title":"J Physiol"},{"issue":"2","key":"4701_CR227","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0006-2952(97)00262-1","volume":"54","author":"A Jovanovic","year":"1997","unstructured":"Jovanovic A, Alekseev AE, Terzic A (1997) Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel. Biochem Pharmacol 54(2):219\u2013225. https:\/\/doi.org\/10.1016\/s0006-2952(97)00262-1","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"4701_CR228","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1476-5381.1996.tb15180.x","volume":"117","author":"A Jovanovic","year":"1996","unstructured":"Jovanovic A, Terzic A (1996) Diadenosine tetraphosphate-induced inhibition of ATP-sensitive K+ channels in patches excised from ventricular myocytes. Br J Pharmacol 117(2):233\u2013235. https:\/\/doi.org\/10.1111\/j.1476-5381.1996.tb15180.x","journal-title":"Br J Pharmacol"},{"issue":"10","key":"4701_CR229","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2337\/diab.45.10.1431","volume":"45","author":"C Ripoll","year":"1996","unstructured":"Ripoll C, Martin F, Manuel Rovira J, Pintor J, Miras-Portugal MT, Soria B (1996) Diadenosine polyphosphates. A novel class of glucose-induced intracellular messengers in the pancreatic beta-cell. Diabetes 45(10):1431\u20131434. https:\/\/doi.org\/10.2337\/diab.45.10.1431","journal-title":"Diabetes"},{"issue":"11","key":"4701_CR230","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1073\/pnas.73.11.3984","volume":"73","author":"E Rapaport","year":"1976","unstructured":"Rapaport E, Zamecnik PC (1976) Presence of diadenosine 5\u2019,5\u2019\" -P1, P4-tetraphosphate (Ap4A) in mammalian cells in levels varying widely with proliferative activity of the tissue: a possible positive \u201cpleiotypic activator.\u201d Proc Natl Acad Sci U S A 73(11):3984\u20133988. https:\/\/doi.org\/10.1073\/pnas.73.11.3984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4701_CR231","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-2362.1990.tb01866.x","volume":"20","author":"K Winther","year":"1990","unstructured":"Winther K, Hedman C, Flodgaard H (1990) Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade. Eur J Clin Invest 20(3):336\u2013338. https:\/\/doi.org\/10.1111\/j.1365-2362.1990.tb01866.x","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"4701_CR232","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1526-4610.1979.hed1906323.x","volume":"19","author":"M Gawel","year":"1979","unstructured":"Gawel M, Burkitt M, Rose FC (1979) The platelet release reaction during migraine attacks. Headache 19(6):323\u2013327. https:\/\/doi.org\/10.1111\/j.1526-4610.1979.hed1906323.x","journal-title":"Headache"},{"key":"4701_CR233","doi-asserted-by":"publisher","unstructured":"Sharda A, Flaumenhaft R (2018) The life cycle of platelet granules. F1000Res 7:236. https:\/\/doi.org\/10.12688\/f1000research.13283.1","DOI":"10.12688\/f1000research.13283.1"},{"issue":"2","key":"4701_CR234","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.thromres.2009.11.006","volume":"125","author":"H Chang","year":"2010","unstructured":"Chang H, Yanachkov IB, Michelson AD, Li Y, Barnard MR, Wright GE, Frelinger AL 3rd (2010) Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. Thromb Res 125(2):159\u2013165. https:\/\/doi.org\/10.1016\/j.thromres.2009.11.006","journal-title":"Thromb Res"},{"issue":"4","key":"4701_CR235","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1124\/mol.62.4.957","volume":"62","author":"SS Wildman","year":"2002","unstructured":"Wildman SS, Brown SG, Rahman M, Noel CA, Churchill L, Burnstock G, Unwin RJ, King BF (2002) Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1). Mol Pharmacol 62(4):957\u2013966. https:\/\/doi.org\/10.1124\/mol.62.4.957","journal-title":"Mol Pharmacol"},{"issue":"1","key":"4701_CR236","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0014-2999(98)00976-5","volume":"367","author":"SS Wildman","year":"1999","unstructured":"Wildman SS, Brown SG, King BF, Burnstock G (1999) Selectivity of diadenosine polyphosphates for rat P2X receptor subunits. Eur J Pharmacol 367(1):119\u2013123. https:\/\/doi.org\/10.1016\/s0014-2999(98)00976-5","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4701_CR237","first-page":"62","volume":"36","author":"MJ Shapiro","year":"1992","unstructured":"Shapiro MJ, Jellinek M, Pyrros D, Sundine M, Baue AE (1992) Clearance and maintenance of blood nucleotide levels with adenosine triphosphate-magnesium chloride injection. Circ Shock 36(1):62\u201367","journal-title":"Circ Shock"},{"issue":"2","key":"4701_CR238","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0378-4347(95)00042-h","volume":"667","author":"K Iwata","year":"1995","unstructured":"Iwata K, Haruki S, Kimura T (1995) High-performance liquid chromatographic determination of diadenosine 5\u2019,5\u2019\"-p1, p4-tetraphosphate with precolumn fluorescence derivatization and its application to metabolism study in whole blood. J Chromatogr B Biomed Appl 667(2):339\u2013343. https:\/\/doi.org\/10.1016\/0378-4347(95)00042-h","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"3","key":"4701_CR239","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/01.res.65.3.531","volume":"65","author":"SB Coade","year":"1989","unstructured":"Coade SB, Pearson JD (1989) Metabolism of adenine nucleotides in human blood. Circ Res 65(3):531\u2013537. https:\/\/doi.org\/10.1161\/01.res.65.3.531","journal-title":"Circ Res"},{"issue":"5 Pt 2","key":"4701_CR240","doi-asserted-by":"publisher","first-page":"H828","DOI":"10.1152\/ajpheart.1988.254.5.H828","volume":"254","author":"R Busse","year":"1988","unstructured":"Busse R, Ogilvie A, Pohl U (1988) Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries. Am J Physiol 254(5 Pt 2):H828-832. https:\/\/doi.org\/10.1152\/ajpheart.1988.254.5.H828","journal-title":"Am J Physiol"},{"issue":"2","key":"4701_CR241","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1124\/jpet.302.2.787","volume":"302","author":"M Steinmetz","year":"2002","unstructured":"Steinmetz M, Janssen AK, Pelster F, Rahn KH, Schlatter E (2002) Vasoactivity of diadenosine polyphosphates in human small mesenteric resistance arteries. J Pharmacol Exp Ther 302(2):787\u2013794. https:\/\/doi.org\/10.1124\/jpet.302.2.787","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"4701_CR242","first-page":"1323","volume":"50","author":"JL Boyer","year":"1996","unstructured":"Boyer JL, Romero-Avila T, Schachter JB, Harden TK (1996) Identification of competitive antagonists of the P2Y1 receptor. Mol Pharmacol 50(5):1323\u20131329","journal-title":"Mol Pharmacol"},{"issue":"12","key":"4701_CR243","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/ndt\/gfg405","volume":"18","author":"M Steinmetz","year":"2003","unstructured":"Steinmetz M, Gabri\u00ebls G, Le TV, Piechota HJ, Rahn KH, Schlatter E (2003) Vasoactivity of diadenosine polyphosphates in human small renal resistance arteries. Nephrol Dial Transplant 18(12):2496\u20132504. https:\/\/doi.org\/10.1093\/ndt\/gfg405","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"4701_CR244","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1159\/000054088","volume":"37","author":"AR Conant","year":"2000","unstructured":"Conant AR, Fisher MJ, McLennan AG, Simpson AW (2000) Diadenosine polyphosphates are largely ineffective as agonists at natively expressed P2Y(1) and P2Y(2) receptors on cultured human saphenous vein endothelial cells. J Vasc Res 37(6):548\u2013555. https:\/\/doi.org\/10.1159\/000054088","journal-title":"J Vasc Res"},{"issue":"2\u20133","key":"4701_CR245","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0163-7258(00)00049-8","volume":"87","author":"J Pintor","year":"2000","unstructured":"Pintor J, D\u00edaz-Hern\u00e1ndez M, Gualix J, G\u00f3mez-Villafuertes R, Hernando F, Miras-Portugal MT (2000) Diadenosine polyphosphate receptors from rat and guinea-pig brain to human nervous system. Pharmacol Ther 87(2\u20133):103\u2013115. https:\/\/doi.org\/10.1016\/s0163-7258(00)00049-8","journal-title":"Pharmacol Ther"},{"issue":"2\u20133","key":"4701_CR246","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0014-2999(98)00922-4","volume":"366","author":"J Pintor","year":"1999","unstructured":"Pintor J, D\u00edaz-Hern\u00e1ndez M, Bustamante C, Gualix J, de Terreros FJ, Miras-Portugal MT (1999) Presence of dinucleotide and ATP receptors in human cerebrocortical synaptic terminals. Eur J Pharmacol 366(2\u20133):159\u2013165. https:\/\/doi.org\/10.1016\/s0014-2999(98)00922-4","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"4701_CR247","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1476-5381.1995.tb15894.x","volume":"115","author":"J Pintor","year":"1995","unstructured":"Pintor J, Miras-Portugal MT (1995) A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes. Br J Pharmacol 115(6):895\u2013902. https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb15894.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"4701_CR248","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/00001756-200103260-00012","volume":"12","author":"R Burgstahler","year":"2001","unstructured":"Burgstahler R, Grafe P (2001) Diadenosine pentaphosphate is more potent than ATP at P2X receptors in isolated rat vagus nerve. NeuroReport 12(4):679\u2013682. https:\/\/doi.org\/10.1097\/00001756-200103260-00012","journal-title":"NeuroReport"},{"issue":"6","key":"4701_CR249","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00170159","volume":"351","author":"DJ Trezise","year":"1995","unstructured":"Trezise DJ, Michel AD, Grahames CB, Khakh BS, Surprenant A, Humphrey PP (1995) The selective P2X purinoceptor agonist, beta, gamma-methylene-L-adenosine 5\u2019-triphosphate, discriminates between smooth muscle and neuronal P2X purinoceptors. Naunyn Schmiedebergs Arch Pharmacol 351(6):603\u2013609. https:\/\/doi.org\/10.1007\/BF00170159","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4701_CR250","doi-asserted-by":"publisher","first-page":"174480691663770","DOI":"10.1177\/1744806916637704","volume":"12","author":"V Viatchenko-Karpinski","year":"2016","unstructured":"Viatchenko-Karpinski V, Novosolova N, Ishchenko Y, Azhar MA, Wright M, Tsintsadze V, Kamal A, Burnashev N, Miller AD, Voitenko N, Giniatullin R, Lozovaya N (2016) Stable, synthetic analogs of diadenosine tetraphosphate inhibit rat and human P2X3 receptors and inflammatory pain. Mol Pain 12:1744806916637704. https:\/\/doi.org\/10.1177\/1744806916637704","journal-title":"Mol Pain"},{"issue":"2","key":"4701_CR251","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0306-4522(94)90030-2","volume":"58","author":"A Klishin","year":"1994","unstructured":"Klishin A, Lozovaya N, Pintor J, Miras-Portugal MT, Krishtal O (1994) Possible functional role of diadenosine polyphosphates: negative feedback for excitation in hippocampus. Neuroscience 58(2):235\u2013236. https:\/\/doi.org\/10.1016\/0306-4522(94)90030-2","journal-title":"Neuroscience"},{"issue":"5","key":"4701_CR252","doi-asserted-by":"publisher","first-page":"H775","DOI":"10.1152\/ajpheart.1981.240.5.H775","volume":"240","author":"DD Heistad","year":"1981","unstructured":"Heistad DD, Marcus ML, Gourley JK, Busija DW (1981) Effect of adenosine and dipyridamole on cerebral blood flow. Am J Physiol 240(5):H775-780. https:\/\/doi.org\/10.1152\/ajpheart.1981.240.5.H775","journal-title":"Am J Physiol"},{"key":"4701_CR253","doi-asserted-by":"publisher","first-page":"173619","DOI":"10.1016\/j.ejphar.2020.173619","volume":"889","author":"S Shaw","year":"2020","unstructured":"Shaw S, Uniyal A, Gadepalli A, Tiwari V, Belinskaia DA, Shestakova NN, Venugopala KN, Deb PK, Tiwari V (2020) Adenosine receptor signalling: probing the potential pathways for the ministration of neuropathic pain. Eur J Pharmacol 889:173619. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173619","journal-title":"Eur J Pharmacol"},{"key":"4701_CR254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.10.031","volume":"338","author":"J Sawynok","year":"2016","unstructured":"Sawynok J (2016) Adenosine receptor targets for pain. Neuroscience 338:1\u201318. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.10.031","journal-title":"Neuroscience"},{"issue":"22","key":"4701_CR255","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.3390\/ijms21228710","volume":"21","author":"F Vincenzi","year":"2020","unstructured":"Vincenzi F, Pasquini S, Borea PA, Varani K (2020) Targeting adenosine receptors: a potential pharmacological avenue for acute and chronic pain. Int J Mol Sci 21(22):8710. https:\/\/doi.org\/10.3390\/ijms21228710","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4701_CR256","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen JF, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u2014what are the challenges? Nat Rev Drug Discov 12(4):265\u2013286. https:\/\/doi.org\/10.1038\/nrd3955","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"4701_CR257","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.tranon.2019.05.018","volume":"12","author":"HR Amouzadeh","year":"2019","unstructured":"Amouzadeh HR, Dimery I, Werner J, Ngarmchamnanrith G, Engwall MJ, Vargas HM, Arrindell D (2019) Clinical implications and translation of an off-target pharmacology profiling hit: adenosine uptake inhibition in vitro. Transl Oncol 12(10):1296\u20131304. https:\/\/doi.org\/10.1016\/j.tranon.2019.05.018","journal-title":"Transl Oncol"},{"issue":"8","key":"4701_CR258","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1468-2982.2006.01137.x","volume":"26","author":"C Kruuse","year":"2006","unstructured":"Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J (2006) Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 26(8):925\u2013933. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01137.x","journal-title":"Cephalalgia"},{"issue":"9","key":"4701_CR259","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/00004647-200209000-00010","volume":"22","author":"C Kruuse","year":"2002","unstructured":"Kruuse C, Thomsen LL, Jacobsen TB, Olesen J (2002) The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab 22(9):1124\u20131131. https:\/\/doi.org\/10.1097\/00004647-200209000-00010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"4701_CR260","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/jcbfm.1987.121","volume":"7","author":"A Sollevi","year":"1987","unstructured":"Sollevi A, Ericson K, Eriksson L, Lindqvist C, Lagerkranser M, Stone-Elander S (1987) Effect of adenosine on human cerebral blood flow as determined by positron emission tomography. J Cereb Blood Flow Metab 7(6):673\u2013678. https:\/\/doi.org\/10.1038\/jcbfm.1987.121","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"4701_CR261","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1161\/01.str.26.9.1572","volume":"26","author":"A Soricelli","year":"1995","unstructured":"Soricelli A, Postiglione A, Cuocolo A, De Chiara S, Ruocco A, Brunetti A, Salvatore M, Ell PJ (1995) Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide Stroke 26(9):1572\u20131576. https:\/\/doi.org\/10.1161\/01.str.26.9.1572","journal-title":"A comparison with acetazolamide Stroke"},{"issue":"2\u20133","key":"4701_CR262","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0014-2999(81)90495-7","volume":"76","author":"GG Yarbrough","year":"1981","unstructured":"Yarbrough GG, McGuffin-Clineschmidt JC (1981) In vivo behavioral assessment of central nervous system purinergic receptors. Eur J Pharmacol 76(2\u20133):137\u2013144. https:\/\/doi.org\/10.1016\/0014-2999(81)90495-7","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4701_CR263","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1476-5381.1986.tb16267.x","volume":"88","author":"J Sawynok","year":"1986","unstructured":"Sawynok J, Sweeney MI, White TD (1986) Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br J Pharmacol 88(4):923\u2013930. https:\/\/doi.org\/10.1111\/j.1476-5381.1986.tb16267.x","journal-title":"Br J Pharmacol"},{"issue":"Pt 6","key":"4701_CR264","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/brain\/awf141","volume":"125","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE (2002) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125(Pt 6):1392\u20131401. https:\/\/doi.org\/10.1093\/brain\/awf141","journal-title":"Brain"},{"issue":"5","key":"4701_CR265","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1213\/01.ANE.0000180994.10087.6F","volume":"101","author":"MH Yoon","year":"2005","unstructured":"Yoon MH, Bae HB, Choi JI (2005) Antinociception of intrathecal adenosine receptor subtype agonists in rat formalin test. Anesth Analg 101(5):1417\u20131421. https:\/\/doi.org\/10.1213\/01.ANE.0000180994.10087.6F","journal-title":"Anesth Analg"},{"issue":"5","key":"4701_CR266","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/00000542-199811000-00010","volume":"89","author":"K Rane","year":"1998","unstructured":"Rane K, Segerdahl M, Goiny M, Sollevi A (1998) Intrathecal adenosine administration: a phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology 89(5):1108\u20131115. https:\/\/doi.org\/10.1097\/00000542-199811000-00010","journal-title":"Anesthesiology"},{"issue":"1","key":"4701_CR267","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pain.0000000000000007","volume":"156","author":"RL Rauck","year":"2015","unstructured":"Rauck RL, North J, Eisenach JC (2015) Intrathecal clonidine and adenosine: effects on pain and sensory processing in patients with chronic regional pain syndrome. Pain 156(1):88\u201395. https:\/\/doi.org\/10.1016\/j.pain.0000000000000007","journal-title":"Pain"},{"key":"4701_CR268","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10194-016-0638-5","volume":"17","author":"M Curto","year":"2016","unstructured":"Curto M, Lionetto L, Negro A, Capi M, Fazio F, Giamberardino MA, Simmaco M, Nicoletti F, Martelletti P (2016) Altered kynurenine pathway metabolites in serum of chronic migraine patients. J Headache Pain 17:47. https:\/\/doi.org\/10.1186\/s10194-016-0638-5","journal-title":"J Headache Pain"},{"issue":"9","key":"4701_CR269","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/cns.13190","volume":"25","author":"YJ Liu","year":"2019","unstructured":"Liu YJ, Chen J, Li X, Zhou X, Hu YM, Chu SF, Peng Y, Chen NH (2019) Research progress on adenosine in central nervous system diseases. CNS Neurosci Ther 25(9):899\u2013910. https:\/\/doi.org\/10.1111\/cns.13190","journal-title":"CNS Neurosci Ther"},{"key":"4701_CR270","doi-asserted-by":"publisher","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, M\u00fcller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol 63(1):1\u201334. https:\/\/doi.org\/10.1124\/pr.110.003285","DOI":"10.1124\/pr.110.003285"},{"issue":"13","key":"4701_CR271","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1523\/JNEUROSCI.17-13-04956.1997","volume":"17","author":"K Biber","year":"1997","unstructured":"Biber K, Klotz KN, Berger M, Gebicke-H\u00e4rter PJ, van Calker D (1997) Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 17(13):4956\u20134964. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-13-04956.1997","journal-title":"J Neurosci"},{"issue":"1","key":"4701_CR272","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pharmthera.2007.09.002","volume":"117","author":"S Gessi","year":"2008","unstructured":"Gessi S, Merighi S, Varani K, Leung E, Mac Lennan S, Borea PA (2008) The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 117(1):123\u2013140. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.09.002","journal-title":"Pharmacol Ther"},{"key":"4701_CR273","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bcp.2017.12.003","volume":"151","author":"ZG Gao","year":"2018","unstructured":"Gao ZG, Inoue A, Jacobson KA (2018) On the G protein-coupling selectivity of the native A2B adenosine receptor. Biochem Pharmacol 151:201\u2013213. https:\/\/doi.org\/10.1016\/j.bcp.2017.12.003","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"4701_CR274","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/01.res.0000012203.21416.14","volume":"90","author":"I Feoktistov","year":"2002","unstructured":"Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T, Biaggioni I (2002) Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ Res 90(5):531\u2013538. https:\/\/doi.org\/10.1161\/01.res.0000012203.21416.14","journal-title":"Circ Res"},{"issue":"2","key":"4701_CR275","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms15022024","volume":"15","author":"S Sheth","year":"2014","unstructured":"Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V (2014) Adenosine receptors: expression, function and regulation. Int J Mol Sci 15(2):2024\u20132052. https:\/\/doi.org\/10.3390\/ijms15022024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4701_CR276","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0197-0186(00)00034-6","volume":"38","author":"RA Cunha","year":"2001","unstructured":"Cunha RA (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38(2):107\u2013125. https:\/\/doi.org\/10.1016\/s0197-0186(00)00034-6","journal-title":"Neurochem Int"},{"issue":"2","key":"4701_CR277","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/jsre.1998.5439","volume":"80","author":"Li Jm","year":"1998","unstructured":"Jm Li, Fenton RA, Wheeler HB, Powell CC, Peyton BD, Cutler BS, Dobson JG Jr (1998) Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res 80(2):357\u2013364. https:\/\/doi.org\/10.1006\/jsre.1998.5439","journal-title":"J Surg Res"},{"issue":"3","key":"4701_CR278","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1124\/jpet.105.091017","volume":"315","author":"PB Hansen","year":"2005","unstructured":"Hansen PB, Hashimoto S, Oppermann M, Huang Y, Briggs JP, Schnermann J (2005) Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 315(3):1150\u20131157. https:\/\/doi.org\/10.1124\/jpet.105.091017","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 1","key":"4701_CR279","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1113\/jphysiol.2002.023440","volume":"544","author":"CJ Ray","year":"2002","unstructured":"Ray CJ, Abbas MR, Coney AM, Marshall JM (2002) Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol 544(Pt 1):195\u2013209. https:\/\/doi.org\/10.1113\/jphysiol.2002.023440","journal-title":"J Physiol"},{"issue":"Pt 1","key":"4701_CR280","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1113\/jphysiol.2005.099390","volume":"570","author":"CJ Ray","year":"2006","unstructured":"Ray CJ, Marshall JM (2006) The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol 570(Pt 1):85\u201396. https:\/\/doi.org\/10.1113\/jphysiol.2005.099390","journal-title":"J Physiol"},{"issue":"1","key":"4701_CR281","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/s0008-6363(97)00068-0","volume":"35","author":"U Ikeda","year":"1997","unstructured":"Ikeda U, Kurosaki K, Ohya K, Shimada K (1997) Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc Res 35(1):168\u2013174. https:\/\/doi.org\/10.1016\/s0008-6363(97)00068-0","journal-title":"Cardiovasc Res"},{"issue":"3","key":"4701_CR282","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0306-3623(01)00107-0","volume":"35","author":"HA Olanrewaju","year":"2000","unstructured":"Olanrewaju HA, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol 35(3):171\u2013177. https:\/\/doi.org\/10.1016\/s0306-3623(01)00107-0","journal-title":"Gen Pharmacol"},{"issue":"1","key":"4701_CR283","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000183755","volume":"78","author":"A Dellabianca","year":"2009","unstructured":"Dellabianca A, Faniglione M, De Angelis S, Tonini S, Balestra B, Colucci M, Cervio M, Clavenzani P, Chiocchetti R, De Giorgio R, Candura SM (2009) Adenosine A1 and A3 receptor agonists inhibit nonadrenergic, noncholinergic relaxations in the guinea pig isolated trachea. Respiration 78(1):75\u201383. https:\/\/doi.org\/10.1159\/000183755","journal-title":"Respiration"},{"issue":"6","key":"4701_CR284","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1211\/0022357021779041","volume":"54","author":"HL Maddock","year":"2002","unstructured":"Maddock HL, Broadley KJ, Bril A, Khandoudi N (2002) Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO. J Pharm Pharmacol 54(6):859\u2013867. https:\/\/doi.org\/10.1211\/0022357021779041","journal-title":"J Pharm Pharmacol"},{"key":"4701_CR285","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1017\/S1462399411002067","volume":"13","author":"AC Raddant","year":"2011","unstructured":"Raddant AC, Russo AF (2011) Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med 13:e36. https:\/\/doi.org\/10.1017\/S1462399411002067","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"4701_CR286","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3892\/br.2016.591","volume":"4","author":"W Lu","year":"2016","unstructured":"Lu W, Li B, Chen J, Su Y, Dong X, Su X, Gao L (2016) Expression of calcitonin gene-related peptide, adenosine A2a receptor and adenosine A1 receptor in experiment rat migraine models. Biomed Rep 4(3):379\u2013383. https:\/\/doi.org\/10.3892\/br.2016.591","journal-title":"Biomed Rep"},{"issue":"8","key":"4701_CR287","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/j.pain.0000000000001246","volume":"159","author":"HW Kan","year":"2018","unstructured":"Kan HW, Chang CH, Lin CL, Lee YC, Hsieh ST, Hsieh YL (2018) Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy. Pain 159(8):1580\u20131591. https:\/\/doi.org\/10.1097\/j.pain.0000000000001246","journal-title":"Pain"},{"issue":"3","key":"4701_CR288","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/brainsci7030030","volume":"7","author":"NT Fried","year":"2017","unstructured":"Fried NT, Elliott MB, Oshinsky ML (2017) The role of adenosine signaling in headache: a review. Brain Sci 7(3):30. https:\/\/doi.org\/10.3390\/brainsci7030030","journal-title":"Brain Sci"},{"issue":"2","key":"4701_CR289","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/sj.bjp.0703048","volume":"129","author":"AM Sebasti\u00e3o","year":"2000","unstructured":"Sebasti\u00e3o AM, Macedo MP, Ribeiro JA (2000) Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. Br J Pharmacol 129(2):374\u2013380. https:\/\/doi.org\/10.1038\/sj.bjp.0703048","journal-title":"Br J Pharmacol"},{"issue":"5","key":"4701_CR290","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pneurobio.2007.04.002","volume":"83","author":"S Ferr\u00e9","year":"2007","unstructured":"Ferr\u00e9 S, Diamond I, Goldberg SR, Yao L, Hourani SM, Huang ZL, Urade Y, Kitchen I (2007) Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol 83(5):332\u2013347. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.04.002","journal-title":"Prog Neurobiol"},{"issue":"3","key":"4701_CR291","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0306-4522(90)90068-f","volume":"38","author":"YO Taiwo","year":"1990","unstructured":"Taiwo YO (1990) Levine JD (1990) Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 38(3):757\u2013762. https:\/\/doi.org\/10.1016\/0306-4522(90)90068-f","journal-title":"Neuroscience"},{"issue":"1","key":"4701_CR292","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0306-4522(91)90255-m","volume":"44","author":"YO Taiwo","year":"1991","unstructured":"Taiwo YO, Levine JD (1991) Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44(1):131\u2013135. https:\/\/doi.org\/10.1016\/0306-4522(91)90255-m","journal-title":"Neuroscience"},{"issue":"1","key":"4701_CR293","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0306-4522(94)00632-f","volume":"67","author":"SG Khasar","year":"1995","unstructured":"Khasar SG, Wang JF, Taiwo YO, Heller PH, Green PG, Levine JD (1995) Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect? Neuroscience 67(1):189\u2013195. https:\/\/doi.org\/10.1016\/0306-4522(94)00632-f","journal-title":"Neuroscience"},{"issue":"6","key":"4701_CR294","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1213\/ane.0b013e318173251f","volume":"106","author":"E Guntz","year":"2008","unstructured":"Guntz E, Dumont H, Pastijn E, d\u2019Exaerde Ade K, Azdad K, Sosnowski M, Schiffmann SN, Gall D (2008) Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents. Anesth Analg 106(6):1882\u20131889. https:\/\/doi.org\/10.1213\/ane.0b013e318173251f","journal-title":"Anesth Analg"},{"key":"4701_CR295","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.bbi.2018.01.005","volume":"69","author":"AJ Kwilasz","year":"2018","unstructured":"Kwilasz AJ, Ellis A, Wieseler J, Loram L, Favret J, McFadden A, Springer K, Falci S, Rieger J, Maier SF, Watkins LR (2018) Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists. Brain Behav Immun 69:470\u2013479. https:\/\/doi.org\/10.1016\/j.bbi.2018.01.005","journal-title":"Brain Behav Immun"},{"key":"4701_CR296","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbi.2013.06.004","volume":"33","author":"LC Loram","year":"2013","unstructured":"Loram LC, Taylor FR, Strand KA, Harrison JA, Rzasalynn R, Sholar P, Rieger J, Maier SF, Watkins LR (2013) Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A\/PKC signaling. Brain Behav Immun 33:112\u2013122. https:\/\/doi.org\/10.1016\/j.bbi.2013.06.004","journal-title":"Brain Behav Immun"},{"issue":"15","key":"4701_CR297","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.3390\/ijms22157952","volume":"22","author":"E Coppi","year":"2021","unstructured":"Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare ML, Pugliese AM, Salvemini D (2021) Uncovering the mechanisms of adenosine receptor-mediated pain control: focus on the A3 receptor subtype. Int J Mol Sci 22(15):7952. https:\/\/doi.org\/10.3390\/ijms22157952","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4701_CR298","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.celrep.2016.05.080","volume":"16","author":"X Hu","year":"2016","unstructured":"Hu X, Adebiyi MG, Luo J, Sun K, Le TT, Zhang Y, Wu H, Zhao S, Karmouty-Quintana H, Liu H, Huang A, Wen YE, Zaika OL, Mamenko M, Pochynyuk OM, Kellems RE, Eltzschig HK, Blackburn MR, Walters ET, Huang D, Hu H, Xia Y (2016) Sustained elevated adenosine via ADORA2B promotes chronic pain through neuro-immune interaction. Cell Rep 16(1):106\u2013119. https:\/\/doi.org\/10.1016\/j.celrep.2016.05.080","journal-title":"Cell Rep"},{"issue":"5","key":"4701_CR299","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1096\/fj.11-201541","volume":"26","author":"Z Chen","year":"2012","unstructured":"Chen Z, Janes K, Chen C, Doyle T, Bryant L, Tosh DK, Jacobson KA, Salvemini D (2012) Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J 26(5):1855\u20131865. https:\/\/doi.org\/10.1096\/fj.11-201541","journal-title":"FASEB J"},{"issue":"1","key":"4701_CR300","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuint.2009.08.011","volume":"56","author":"M Zhang","year":"2010","unstructured":"Zhang M, Hu H, Zhang X, Lu W, Lim J, Eysteinsson T, Jacobson KA, Laties AM, Mitchell CH (2010) The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells. Neurochem Int 56(1):35\u201341. https:\/\/doi.org\/10.1016\/j.neuint.2009.08.011","journal-title":"Neurochem Int"},{"issue":"3","key":"4701_CR301","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0896-6273(95)90155-8","volume":"15","author":"IM Mintz","year":"1995","unstructured":"Mintz IM, Sabatini BL, Regehr WG (1995) Calcium control of transmitter release at a cerebellar synapse. Neuron 15(3):675\u2013688. https:\/\/doi.org\/10.1016\/0896-6273(95)90155-8","journal-title":"Neuron"},{"issue":"6","key":"4701_CR302","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.neuropharm.2011.01.039","volume":"60","author":"RE Hampson","year":"2011","unstructured":"Hampson RE, Miller F, Palchik G, Deadwyler SA (2011) Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 60(6):944\u2013952. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.039","journal-title":"Neuropharmacology"},{"issue":"15","key":"4701_CR303","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1523\/JNEUROSCI.4495-14.2015","volume":"35","author":"A Ford","year":"2015","unstructured":"Ford A, Castonguay A, Cottet M, Little JW, Chen Z, Symons-Liguori AM, Doyle T, Egan TM, Vanderah TW, De Koninck Y, Tosh DK, Jacobson KA, Salvemini D (2015) Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain. J Neurosci 35(15):6057\u20136067. https:\/\/doi.org\/10.1523\/JNEUROSCI.4495-14.2015","journal-title":"J Neurosci"},{"issue":"12","key":"4701_CR304","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1007\/s00221-018-5377-1","volume":"236","author":"R Terayama","year":"2018","unstructured":"Terayama R, Tabata M, Maruhama K, Iida S (2018) A3 adenosine receptor agonist attenuates neuropathic pain by suppressing activation of microglia and convergence of nociceptive inputs in the spinal dorsal horn. Exp Brain Res 236(12):3203\u20133213. https:\/\/doi.org\/10.1007\/s00221-018-5377-1","journal-title":"Exp Brain Res"},{"issue":"3","key":"4701_CR305","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/s0306-4522(02)00273-7","volume":"114","author":"WP Wu","year":"2002","unstructured":"Wu WP, Hao JX, Halldner-Henriksson L, Xu XJ, Jacobson MA, Wiesenfeld-Hallin Z, Fredholm BB (2002) Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors. Neuroscience 114(3):523\u2013527. https:\/\/doi.org\/10.1016\/s0306-4522(02)00273-7","journal-title":"Neuroscience"},{"issue":"4","key":"4701_CR306","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1124\/pr.110.002667","volume":"62","author":"NJ Smith","year":"2010","unstructured":"Smith NJ, Milligan G (2010) Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 62(4):701\u2013725. https:\/\/doi.org\/10.1124\/pr.110.002667","journal-title":"Pharmacol Rev"},{"issue":"8","key":"4701_CR307","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nmeth.1229","volume":"5","author":"P Carriba","year":"2008","unstructured":"Carriba P, Navarro G, Ciruela F, Ferr\u00e9 S, Casad\u00f3 V, Agnati L, Cort\u00e9s A, Mallol J, Fuxe K, Canela EI, Llu\u00eds C, Franco R (2008) Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 5(8):727\u2013733. https:\/\/doi.org\/10.1038\/nmeth.1229","journal-title":"Nat Methods"},{"issue":"18","key":"4701_CR308","doi-asserted-by":"publisher","first-page":"11940","DOI":"10.1073\/pnas.172393799","volume":"99","author":"S Ferr\u00e9","year":"2002","unstructured":"Ferr\u00e9 S, Karcz-Kubicha M, Hope BT, Popoli P, Burgue\u00f1o J, Guti\u00e9rrez MA, Casad\u00f3 V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A 99(18):11940\u201311945. https:\/\/doi.org\/10.1073\/pnas.172393799","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"4701_CR309","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1007\/s00018-021-03761-6","volume":"78","author":"R Franco","year":"2021","unstructured":"Franco R, Cordom\u00ed A, Llinas Del Torrent C, Lillo A, Serrano-Mar\u00edn J, Navarro G, Pardo L (2021) Structure and function of adenosine receptor heteromers. Cell Mol Life Sci 78(8):3957\u20133968. https:\/\/doi.org\/10.1007\/s00018-021-03761-6","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"4701_CR310","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.bbamcr.2008.07.006","volume":"1783","author":"SJ Briddon","year":"2008","unstructured":"Briddon SJ, Gand\u00eda J, Amaral OB, Ferr\u00e9 S, Llu\u00eds C, Franco R, Hill SJ, Ciruela F (2008) Plasma membrane diffusion of G protein-coupled receptor oligomers. Biochim Biophys Acta 1783(12):2262\u20132268. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.07.006","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"4701_CR311","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1096\/fj.11-186296","volume":"25","author":"LT May","year":"2011","unstructured":"May LT, Bridge LJ, Stoddart LA, Briddon SJ, Hill SJ (2011) Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics. FASEB J 25(10):3465\u20133476. https:\/\/doi.org\/10.1096\/fj.11-186296","journal-title":"FASEB J"},{"issue":"3","key":"4701_CR312","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1046\/j.1471-4159.2003.02200.x","volume":"88","author":"M Canals","year":"2004","unstructured":"Canals M, Burgue\u00f1o J, Marcellino D, Cabello N, Canela EI, Mallol J, Agnati L, Ferr\u00e9 S, Bouvier M, Fuxe K, Ciruela F, Lluis C, Franco R (2004) Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem 88(3):726\u2013734. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02200.x","journal-title":"J Neurochem"},{"issue":"29","key":"4701_CR313","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1016\/j.febslet.2008.09.062","volume":"582","author":"PA Vidi","year":"2008","unstructured":"Vidi PA, Chen J, Irudayaraj JM, Watts VJ (2008) Adenosine A(2A) receptors assemble into higher-order oligomers at the plasma membrane. FEBS Lett 582(29):3985\u20133990. https:\/\/doi.org\/10.1016\/j.febslet.2008.09.062","journal-title":"FEBS Lett"},{"key":"4701_CR314","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuropharm.2013.03.005","volume":"71","author":"E Gracia","year":"2013","unstructured":"Gracia E, Moreno E, Cort\u00e9s A, Llu\u00eds C, Mallol J, McCormick PJ, Canela EI, Casad\u00f3 V (2013) Homodimerization of adenosine A1 receptors in brain cortex explains the biphasic effects of caffeine. Neuropharmacology 71:56\u201369. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.03.005","journal-title":"Neuropharmacology"},{"issue":"7","key":"4701_CR315","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","volume":"26","author":"F Ciruela","year":"2006","unstructured":"Ciruela F, Casad\u00f3 V, Rodrigues RJ, Luj\u00e1n R, Burgue\u00f1o J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cort\u00e9s A, Canela EI, L\u00f3pez-Gim\u00e9nez JF, Milligan G, Lluis C, Cunha RA, Ferr\u00e9 S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1\u2013A2A receptor heteromers. J Neurosci 26(7):2080\u20132087. https:\/\/doi.org\/10.1523\/JNEUROSCI.3574-05.2006","journal-title":"J Neurosci"},{"key":"4701_CR316","doi-asserted-by":"publisher","unstructured":"Hinz S, Navarro G, Borroto-Escuela D, Seibt BF, Ammon YC, de Filippo E, Danish A, Lacher SK, \u010cervinkov\u00e1 B, Rafehi M, Fuxe K, Schiedel AC, Franco R, M\u00fcller CE (2018) Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors. Oncotarget 9(17):13593\u201313611. https:\/\/doi.org\/10.18632\/oncotarget.24423","DOI":"10.18632\/oncotarget.24423"},{"issue":"14","key":"4701_CR317","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.3390\/ijms21145070","volume":"21","author":"A Lillo","year":"2020","unstructured":"Lillo A, Mart\u00ednez-Pinilla E, Reyes-Resina I, Navarro G, Franco R (2020) Adenosine A2A and A3 receptors are able to interact with each other. A further piece in the puzzle of adenosine receptor-mediated signaling. Int J Mol Sci 21(14):5070. https:\/\/doi.org\/10.3390\/ijms21145070","journal-title":"Int J Mol Sci"},{"key":"4701_CR318","doi-asserted-by":"publisher","unstructured":"Nascimento FP, Macedo-J\u00fanior SJ, Lapa-Costa FR, Cezar-Dos-Santos F, Santos ARS (2021) Inosine as a tool to understand and treat central nervous system disorders: a neglected actor? Front Neurosci 15:703783. https:\/\/doi.org\/10.3389\/fnins.2021.703783","DOI":"10.3389\/fnins.2021.703783"},{"issue":"14","key":"4701_CR319","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jama.1899.92450660027001h","volume":"33","author":"JA Lichty","year":"1889","unstructured":"Lichty JA (1889) Relation of uric acid to migraine. JAMA 33(14):837\u2013839","journal-title":"JAMA"},{"key":"4701_CR320","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/095952878707000124","volume":"70","author":"A Haig","year":"1887","unstructured":"Haig A (1887) The relation of a certain form of headache to the excretion of uric acid. Med Chir Trans 70:355\u2013369. https:\/\/doi.org\/10.1177\/095952878707000124","journal-title":"Med Chir Trans"},{"issue":"2","key":"4701_CR321","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.02.067","volume":"474","author":"AP Schmidt","year":"2010","unstructured":"Schmidt AP, B\u00f6hmer AE, Soares FA, Posso IP, Machado SB, Mendes FF, Portela LV, Souza DO (2010) Changes in purines concentration in the cerebrospinal fluid of patients experiencing pain: a case\u2013control study. Neurosci Lett 474(2):69\u201373. https:\/\/doi.org\/10.1016\/j.neulet.2010.02.067","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"4701_CR322","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clinbiochem.2012.09.009","volume":"46","author":"A Fais","year":"2013","unstructured":"Fais A, Cacace E, Corda M, Era B, Peri M, Utzeri S, Ruggiero V (2013) Purine metabolites in fibromyalgia syndrome. Clin Biochem 46(1\u20132):37\u201339. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.009","journal-title":"Clin Biochem"},{"issue":"1467","key":"4701_CR323","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/bmj.1.1467.288","volume":"1","author":"A Haig","year":"1889","unstructured":"Haig A (1889) On uric acid and arterial tension. Br Med J 1(1467):288\u2013291. https:\/\/doi.org\/10.1136\/bmj.1.1467.288","journal-title":"Br Med J"},{"issue":"2","key":"4701_CR324","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10072-020-04598-w","volume":"42","author":"T Yazar","year":"2021","unstructured":"Yazar T, Yazar HO, Ayg\u00fcn A, Karabacak V, Altunkaynak Y, Kirba\u015f D (2021) Evaluation of serum uric levels in migraine. Neurol Sci 42(2):705\u2013709. https:\/\/doi.org\/10.1007\/s10072-020-04598-w","journal-title":"Neurol Sci"},{"key":"4701_CR325","unstructured":"Schulte G (2002) Adenosine receptor signaling and the activation of mitogen-activated protein kinases. Institutionen f\u00f6r fysiologi och farmakologi\/Department of Physiology and Pharmacology. https:\/\/openarchive.ki.se\/xmlui\/bitstream\/handle\/10616\/37706\/thesis.pdf?sequence=1&isAllowed=y"},{"issue":"6","key":"4701_CR326","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cellsig.2016.02.010","volume":"28","author":"AA Welihinda","year":"2016","unstructured":"Welihinda AA, Kaur M, Greene K, Zhai Y, Amento EP (2016) The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias. Cell Signal 28(6):552\u2013560. https:\/\/doi.org\/10.1016\/j.cellsig.2016.02.010","journal-title":"Cell Signal"},{"issue":"4","key":"4701_CR327","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/s0006-2952(00)00570-0","volume":"61","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443\u2013448. https:\/\/doi.org\/10.1016\/s0006-2952(00)00570-0","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"4701_CR328","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/01.STR.0000155747.15679.04","volume":"36","author":"H Shen","year":"2005","unstructured":"Shen H, Chen GJ, Harvey BK, Bickford PC, Wang Y (2005) Inosine reduces ischemic brain injury in rats. Stroke 36(3):654\u2013659. https:\/\/doi.org\/10.1161\/01.STR.0000155747.15679.04","journal-title":"Stroke"},{"key":"4701_CR329","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cellsig.2017.11.002","volume":"42","author":"AA Welihinda","year":"2018","unstructured":"Welihinda AA, Kaur M, Raveendran KS, Amento EP (2018) Enhancement of inosine-mediated A2AR signaling through positive allosteric modulation. Cell Signal 42:227\u2013235. https:\/\/doi.org\/10.1016\/j.cellsig.2017.11.002","journal-title":"Cell Signal"},{"issue":"3","key":"4701_CR330","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0031-6989(80)80003-8","volume":"12","author":"RL Prewitt","year":"1980","unstructured":"Prewitt RL, Sullivan JM (1980) Vasoactivity of inosine in the rat. Pharmacol Res Commun 12(3):205\u2013213. https:\/\/doi.org\/10.1016\/s0031-6989(80)80003-8","journal-title":"Pharmacol Res Commun"},{"issue":"3","key":"4701_CR331","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00005344-198105000-00019","volume":"3","author":"CE Jones","year":"1981","unstructured":"Jones CE, Mayer LR, Smith EE, Hurst TW (1981) Relaxation of the isolated coronary artery by inosine: noninvolvement of the adenosine receptor. J Cardiovasc Pharmacol 3(3):612\u2013621. https:\/\/doi.org\/10.1097\/00005344-198105000-00019","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3 Pt 2","key":"4701_CR332","doi-asserted-by":"publisher","first-page":"H759","DOI":"10.1152\/ajpheart.1990.259.3.H759","volume":"259","author":"P Van der Meer","year":"1990","unstructured":"Van der Meer P, de Jong JW (1990) Inosine transiently decreases coronary flow but potentiates vasodilation by adenosine. Am J Physiol 259(3 Pt 2):H759-765. https:\/\/doi.org\/10.1152\/ajpheart.1990.259.3.H759","journal-title":"Am J Physiol"},{"issue":"3","key":"4701_CR333","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s12035-014-8815-5","volume":"51","author":"FP Nascimento","year":"2015","unstructured":"Nascimento FP, Macedo-J\u00fanior SJ, Pamplona FA, Luiz-Cerutti M, C\u00f3rdova MM, Constantino L, Tasca CI, Dutra RC, Calixto JB, Reid A, Sawynok J, Santos AR (2015) Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects. Mol Neurobiol 51(3):1368\u20131378. https:\/\/doi.org\/10.1007\/s12035-014-8815-5","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4701_CR334","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11302-021-09781-y","volume":"17","author":"SJ Macedo-J\u00fanior","year":"2021","unstructured":"Macedo-J\u00fanior SJ, Nascimento FP, Luiz-Cerutti M, Santos ARS (2021) The role of peripheral adenosine receptors in glutamate-induced pain nociceptive behavior. Purinergic Signal 17(2):303\u2013312. https:\/\/doi.org\/10.1007\/s11302-021-09781-y","journal-title":"Purinergic Signal"},{"issue":"8","key":"4701_CR335","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/bph.12262","volume":"169","author":"AR Cinalli","year":"2013","unstructured":"Cinalli AR, Guarracino JF, Fernandez V, Roquel LI, Losavio AS (2013) Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction. Br J Pharmacol 169(8):1810\u20131823. https:\/\/doi.org\/10.1111\/bph.12262","journal-title":"Br J Pharmacol"},{"issue":"26","key":"4701_CR336","first-page":"1035","volume":"49","author":"H Isaacs","year":"1975","unstructured":"Isaacs H, Heffron JJ, Berman L, Badenhorst M, Pickering A (1975) Xanthine, hypoxanthine and muscle pain. Histochemical and biochemical observations. S Afr Med J 49(26):1035\u20131038","journal-title":"S Afr Med J"},{"key":"4701_CR337","unstructured":"Goldstein KM (2017) Xanthine Oxidase Inhibitors and Their Role in Neuropathic Pain. Dissertation, Harvard University. http:\/\/nrs.harvard.edu\/urn-3:HUL.InstRepos:37736766"},{"issue":"10","key":"4701_CR338","doi-asserted-by":"publisher","first-page":"e00829","DOI":"10.1016\/j.heliyon.2018.e00829","volume":"4","author":"N Singh","year":"2018","unstructured":"Singh N, Shreshtha AK, Thakur MS, Patra S (2018) Xanthine scaffold: scope and potential in drug development. Heliyon 4(10):e00829. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00829","journal-title":"Heliyon"},{"issue":"7","key":"4701_CR339","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1073\/pnas.80.7.2077","volume":"80","author":"RF Bruns","year":"1983","unstructured":"Bruns RF, Daly JW, Snyder SH (1983) Adenosine receptor binding: structure\u2013activity analysis generates extremely potent xanthine antagonists. Proc Natl Acad Sci U S A 80(7):2077\u20132080. https:\/\/doi.org\/10.1073\/pnas.80.7.2077","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4701_CR340","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ (2008) Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27(6):608\u2013619. https:\/\/doi.org\/10.1080\/15257770802138558","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"10","key":"4701_CR341","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/qjmed\/95.10.691","volume":"95","author":"WS Waring","year":"2002","unstructured":"Waring WS (2002) Uric acid: an important antioxidant in acute ischaemic stroke. QJM 95(10):691\u2013693. https:\/\/doi.org\/10.1093\/qjmed\/95.10.691","journal-title":"QJM"},{"issue":"2","key":"4701_CR342","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.15419\/bmrat.v6i2.522","volume":"6","author":"A Khosravi","year":"2019","unstructured":"Khosravi A, Nakhaee A, Ghoreishi A, Arefpoor Z, Sadeghi M (2019) Impaired oxidative-antioxidative balance during migraine attack. Biomed Res Ther 6(2):2996\u20133002","journal-title":"Biomed Res Ther"},{"issue":"1","key":"4701_CR343","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12883-019-1555-4","volume":"19","author":"M Togha","year":"2019","unstructured":"Togha M, RazeghiJahromi S, Ghorbani Z, Ghaemi A, Rafiee P (2019) An investigation of oxidant\/antioxidant balance in patients with migraine: a case\u2013control study. BMC Neurol 19(1):323. https:\/\/doi.org\/10.1186\/s12883-019-1555-4","journal-title":"BMC Neurol"},{"issue":"2","key":"4701_CR344","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5732\/cjc.011.10329","volume":"31","author":"K Sodani","year":"2012","unstructured":"Sodani K, Patel A, Kathawala RJ, Chen ZS (2012) Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer 31(2):58\u201372. https:\/\/doi.org\/10.5732\/cjc.011.10329","journal-title":"Chin J Cancer"},{"issue":"2","key":"4701_CR345","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1468-2982.1981.tb00014.x","volume":"1","author":"M Anthony","year":"1981","unstructured":"Anthony M (1981) Biochemical indices of sympathetic activity in migraine. Cephalalgia 1(2):83\u201389. https:\/\/doi.org\/10.1111\/j.1468-2982.1981.tb00014.x","journal-title":"Cephalalgia"},{"issue":"11","key":"4701_CR346","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1468-2982.2006.01218.x","volume":"26","author":"S Birk","year":"2006","unstructured":"Birk S, Kruuse C, Petersen KA, Tfelt-Hansen P, Olesen J (2006) The headache-inducing effect of cilostazol in human volunteers. Cephalalgia 26(11):1304\u20131309. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01218.x","journal-title":"Cephalalgia"},{"issue":"Pt 11","key":"4701_CR347","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awu244","volume":"137","author":"S Guo","year":"2014","unstructured":"Guo S, Olesen J (2014) Ashina M (2014) Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain 137(Pt 11):2951\u20132959. https:\/\/doi.org\/10.1093\/brain\/awu244","journal-title":"Brain"},{"issue":"14","key":"4701_CR348","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1177\/0333102419882474","volume":"39","author":"S Younis","year":"2019","unstructured":"Younis S, Christensen CE, Toft NM, S\u00f8borg T, Amin FM, Hougaard A, Ashina M (2019) Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil. Cephalalgia 39(14):1776\u20131788. https:\/\/doi.org\/10.1177\/0333102419882474","journal-title":"Cephalalgia"},{"issue":"1","key":"4701_CR349","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1468-2982.2001.00142.x","volume":"21","author":"N Galeotti","year":"2001","unstructured":"Galeotti N, Ghelardini C, Zoppi M, Del Bene E, Raimondi L, Beneforti E, Bartolini A (2001) Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia 21(1):38\u201345. https:\/\/doi.org\/10.1046\/j.1468-2982.2001.00142.x","journal-title":"Cephalalgia"},{"issue":"1\u20133","key":"4701_CR350","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000158852","volume":"28","author":"TM Lincoln","year":"1991","unstructured":"Lincoln TM, Cornwell TL (1991) Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28(1\u20133):129\u2013137. https:\/\/doi.org\/10.1159\/000158852","journal-title":"Blood Vessels"},{"issue":"8","key":"4701_CR351","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.res.86.8.897","volume":"86","author":"RE White","year":"2000","unstructured":"White RE, Kryman JP, El-Mowafy AM, Han G, Carrier GO (2000) cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BK(Ca) channel activity in coronary artery smooth muscle cells. Circ Res 86(8):897\u2013905. https:\/\/doi.org\/10.1161\/01.res.86.8.897","journal-title":"Circ Res"},{"issue":"12","key":"4701_CR352","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11916-020-00911-6","volume":"24","author":"L Kokoti","year":"2020","unstructured":"Kokoti L, Al-Karagholi MA, Ashina M (2020) Latest insights into the pathophysiology of migraine: the ATP-sensitive potassium channels. Curr Pain Headache Rep 24(12):77. https:\/\/doi.org\/10.1007\/s11916-020-00911-6","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"4701_CR353","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s10194-022-01412-0","volume":"23","author":"J Thuraiaiyah","year":"2022","unstructured":"Thuraiaiyah J, Kokoti L, Al-Karagholi MA, Ashina M (2022) Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies. J Headache Pain 23(1):43. https:\/\/doi.org\/10.1186\/s10194-022-01412-0","journal-title":"J Headache Pain"},{"issue":"3","key":"4701_CR354","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11302-015-9453-8","volume":"11","author":"M Cie\u015blak","year":"2015","unstructured":"Cie\u015blak M, Czarnecka J, Roszek K, Komoszy\u0144ski M (2015) The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment. Purinergic Signal 11(3):307\u2013316. https:\/\/doi.org\/10.1007\/s11302-015-9453-8","journal-title":"Purinergic Signal"},{"issue":"6","key":"4701_CR355","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40263-019-00630-6","volume":"33","author":"KA Haanes","year":"2019","unstructured":"Haanes KA, Edvinsson L (2019) Pathophysiological mechanisms in migraine and the identification of new therapeutic targets. CNS Drugs 33(6):525\u2013537. https:\/\/doi.org\/10.1007\/s40263-019-00630-6","journal-title":"CNS Drugs"},{"issue":"8","key":"4701_CR356","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/nu12082259","volume":"12","author":"M Nowaczewska","year":"2020","unstructured":"Nowaczewska M, Wici\u0144ski M, Ka\u017amierczak W (2020) The ambiguous role of caffeine in migraine headache: from trigger to treatment. Nutrients 12(8):2259. https:\/\/doi.org\/10.3390\/nu12082259","journal-title":"Nutrients"},{"issue":"6","key":"4701_CR357","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10245330310001621260","volume":"8","author":"RT Dorsam","year":"2003","unstructured":"Dorsam RT, Murugappan S, Ding Z, Kunapuli SP (2003) Clopidogrel: interactions with the P2Y12 receptor and clinical relevance. Hematology 8(6):359\u2013365. https:\/\/doi.org\/10.1080\/10245330310001621260","journal-title":"Hematology"},{"issue":"14","key":"4701_CR358","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/0333102414531156","volume":"34","author":"JB Chambers","year":"2014","unstructured":"Chambers JB, Seed PT, Ridsdale L (2014) Clopidogrel as prophylactic treatment for migraine: a pilot randomised, controlled study. Cephalalgia 34(14):1163\u20131168. https:\/\/doi.org\/10.1177\/0333102414531156","journal-title":"Cephalalgia"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04701-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T08:11:42Z","timestamp":1699258302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04701-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":358,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["4701"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04701-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}